activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1512979	CHEMBL830019	Inhibition of human receptor-interacting serine-threonine kinase 2 (RIPK2) at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	nM	16.0
	1512979	CHEMBL830019	Inhibition of human receptor-interacting serine-threonine kinase 2 (RIPK2) at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	nM	16.0
Not Active	1650468	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1650469	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1650470	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1650471	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1650472	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1650473	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL5014	Homo sapiens	Kd		
	1650474	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2900.0	CHEMBL5014	Homo sapiens	Kd	uM	2.9
Not Active	1650475	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1650476	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL5014	Homo sapiens	Kd		
	1651434	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	5100.0	CHEMBL5014	Homo sapiens	Kd	uM	5.1
	1651435	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	350.0	CHEMBL5014	Homo sapiens	Kd	uM	0.35
	1651436	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	2100.0	CHEMBL5014	Homo sapiens	Kd	uM	2.1
Not Active	1651437	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1651438	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1651439	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL5014	Homo sapiens	Kd		
Not Active	1651440	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL5014	Homo sapiens	Kd		
	1651441	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	800.0	CHEMBL5014	Homo sapiens	Kd	uM	0.8
	1651442	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	410.0	CHEMBL5014	Homo sapiens	Kd	uM	0.41
	1651443	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	31.0	CHEMBL5014	Homo sapiens	Kd	uM	0.031
	1651444	CHEMBL860788	Average Binding Constant for RIPK2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	330.0	CHEMBL5014	Homo sapiens	Kd	uM	0.33
	2147373	CHEMBL922158	Activity of human RIPK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	88.0	CHEMBL5014	Homo sapiens	Activity	%	88.0
	2470341	CHEMBL995020	Inhibition of RIPK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5014	Homo sapiens	INH	%	10.0
Not Evaluated	2476679	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2476882	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2478721	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5014	Homo sapiens	Activity		
	2479779	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	23.3	CHEMBL5014	Homo sapiens	Activity	%	23.3
Not Evaluated	2480576	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5014	Homo sapiens	Activity		
	2480778	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	6.9	CHEMBL5014	Homo sapiens	Activity	%	6.9
	2567278	CHEMBL975465	Inhibition of human RIPK2 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	95.0	CHEMBL5014	Homo sapiens	Activity	%	95.0
Not Evaluated	2577400	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2593605	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL5014	Homo sapiens	Activity		
Active	2593808	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2593871	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5014	Homo sapiens	Activity		
Active	2594074	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2595017	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2595286	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2596214	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Evaluated	2596417	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5014	Homo sapiens	Activity		
	2597686	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	21.6	CHEMBL5014	Homo sapiens	Activity	%	21.6
	2597889	CHEMBL1025751	Binding affinity to human RIPK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Activity	%	26.6	CHEMBL5014	Homo sapiens	Activity	%	26.6
	2721708	CHEMBL1055110	Inhibition of RIPK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
Antagonist	2897344	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	IC50	nM	120.0	CHEMBL5014	Homo sapiens	IC50	uM	0.12
Antagonist	2897345	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	19.0	CHEMBL5014	Homo sapiens	IC50	uM	0.019
Antagonist	2897346	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	130.0	CHEMBL5014	Homo sapiens	IC50	uM	0.13
Antagonist	2897347	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	>	IC50	nM	100000.0	CHEMBL5014	Homo sapiens	IC50	uM	100.0
Antagonist	2897348	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3600.0	CHEMBL5014	Homo sapiens	IC50	uM	3.6
Antagonist	2897349	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	IC50	nM	26.0	CHEMBL5014	Homo sapiens	IC50	uM	0.026
Antagonist	2897350	CHEMBL1051329	Inhibition of RIP2 in the presence of 100uM ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	26.0	CHEMBL5014	Homo sapiens	IC50	uM	0.026
	2907513	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907514	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907515	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1100.0	CHEMBL5014	Homo sapiens	Kd	nM	1100.0
	2907516	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1800.0	CHEMBL5014	Homo sapiens	Kd	nM	1800.0
	2907517	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907518	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907519	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907520	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	950.0	CHEMBL5014	Homo sapiens	Kd	nM	950.0
	2907521	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	300.0	CHEMBL5014	Homo sapiens	Kd	nM	300.0
	2907522	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907523	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907524	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	31.0	CHEMBL5014	Homo sapiens	Kd	nM	31.0
	2907525	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907526	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	680.0	CHEMBL5014	Homo sapiens	Kd	nM	680.0
	2907527	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907528	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	530.0	CHEMBL5014	Homo sapiens	Kd	nM	530.0
	2907529	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907530	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	580.0	CHEMBL5014	Homo sapiens	Kd	nM	580.0
	2907531	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907532	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907533	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	3600.0	CHEMBL5014	Homo sapiens	Kd	nM	3600.0
	2907534	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907535	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907536	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907537	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907538	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907539	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907540	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907541	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	150.0	CHEMBL5014	Homo sapiens	Kd	nM	150.0
	2907542	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	24.0	CHEMBL5014	Homo sapiens	Kd	nM	24.0
	2907543	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Kd	nM	3400.0	CHEMBL5014	Homo sapiens	Kd	nM	3400.0
	2907544	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1300.0	CHEMBL5014	Homo sapiens	Kd	nM	1300.0
	2907545	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	5200.0	CHEMBL5014	Homo sapiens	Kd	nM	5200.0
	2907546	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907547	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907548	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907549	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	2907550	CHEMBL1051312	Binding constant for RIPK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	4.6	CHEMBL5014	Homo sapiens	Kd	nM	4.6
Antagonist	2908255	CHEMBL1052973	Percentage RIP2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	6.0	CHEMBL5014	Homo sapiens	Activity	%	6.0
Antagonist	2908256	CHEMBL1052973	Percentage RIP2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	5.0	CHEMBL5014	Homo sapiens	Activity	%	5.0
	2908257	CHEMBL1052973	Percentage RIP2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	92.0	CHEMBL5014	Homo sapiens	Activity	%	92.0
Antagonist	2908258	CHEMBL1052973	Percentage RIP2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	26.0	CHEMBL5014	Homo sapiens	Activity	%	26.0
	2908259	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	101.0	CHEMBL5014	Homo sapiens	Activity	%	101.0
Antagonist	2908260	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	7.0	CHEMBL5014	Homo sapiens	Activity	%	7.0
Antagonist	2908261	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	7.0	CHEMBL5014	Homo sapiens	Activity	%	7.0
Antagonist	2908262	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	35.0	CHEMBL5014	Homo sapiens	Activity	%	35.0
Antagonist	2908263	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	10.0	CHEMBL5014	Homo sapiens	Activity	%	10.0
Antagonist	2908264	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	7.0	CHEMBL5014	Homo sapiens	Activity	%	7.0
Antagonist	2908265	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	14.0	CHEMBL5014	Homo sapiens	Activity	%	14.0
Antagonist	2908266	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	9.0	CHEMBL5014	Homo sapiens	Activity	%	9.0
Antagonist	2908267	CHEMBL1062023	Percentage RIP2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	9.0	CHEMBL5014	Homo sapiens	Activity	%	9.0
	2921980	CHEMBL1052948	Inhibition of RIPK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	2928494	CHEMBL1043886	Binding affinity to RIPK2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	2.9	CHEMBL5014	Homo sapiens	Activity	%	2.9
	3052466	CHEMBL1072504	Residual activity of RIPK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	72.0	CHEMBL5014	Homo sapiens	Residual activity	%	72.0
	3052718	CHEMBL1043797	Residual activity of RIPK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	29.0	CHEMBL5014	Homo sapiens	Residual activity	%	29.0
	3054027	CHEMBL1071357	Residual activity of RIPK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	1.0	CHEMBL5014	Homo sapiens	Residual activity	%	1.0
	3055314	CHEMBL1072504	Residual activity of RIPK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	78.0	CHEMBL5014	Homo sapiens	Residual activity	%	78.0
	3055566	CHEMBL1043797	Residual activity of RIPK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	25.0	CHEMBL5014	Homo sapiens	Residual activity	%	25.0
	3056871	CHEMBL1071357	Residual activity of RIPK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	2.0	CHEMBL5014	Homo sapiens	Residual activity	%	2.0
	3057123	CHEMBL1072504	Residual activity of RIPK2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	79.0	CHEMBL5014	Homo sapiens	Residual activity	%	79.0
	3058443	CHEMBL1043797	Residual activity of RIPK2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	29.0	CHEMBL5014	Homo sapiens	Residual activity	%	29.0
	3059727	CHEMBL1071357	Residual activity of RIPK2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	4.0	CHEMBL5014	Homo sapiens	Residual activity	%	4.0
	3261340	CHEMBL1108059	Inhibition of RIPK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	10.0	CHEMBL5014	Homo sapiens	Activity	%	10.0
	3261364	CHEMBL1108059	Inhibition of RIPK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	10.0	CHEMBL5014	Homo sapiens	Activity	%	10.0
	3332133	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3333548	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3334953	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3336373	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3337640	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3338971	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3339225	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3340528	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3341915	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3343362	CHEMBL1166844	Inhibition of RIPK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	3358788	CHEMBL1175254	Inhibition of RIPK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.45	CHEMBL5014	Homo sapiens	INH	%	0.45
	3359230	CHEMBL1175254	Inhibition of RIPK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.3	CHEMBL5014	Homo sapiens	INH	%	0.3
Not Active	3395896	CHEMBL1221006	Inhibition of human RIP2 autophosphorylation expressed in HEK293T cells	B	CN1C(=O)C(Cc2c[nH]c3ccccc23)NC1=S		CHEMBL195008		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Active	3395934	CHEMBL1221006	Inhibition of human RIP2 autophosphorylation expressed in HEK293T cells	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	3445285	CHEMBL1244959	Binding affinity to RIPK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	640.0	CHEMBL5014	Homo sapiens	Kd	nM	640.0
	3446254	CHEMBL1244601	Inhibition of RIPK2 at 10 mM	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Inhibition	%	28.0	CHEMBL5014	Homo sapiens	INH	%	28.0
	3446267	CHEMBL1244589	Inhibition of RIPK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	109.0	CHEMBL5014	Homo sapiens	IC50	nM	109.0
	3448606	CHEMBL1244959	Binding affinity to RIPK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	3449500	CHEMBL1244959	Binding affinity to RIPK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1300.0	CHEMBL5014	Homo sapiens	Kd	nM	1300.0
	3449833	CHEMBL1244959	Binding affinity to RIPK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	3450411	CHEMBL1244959	Binding affinity to RIPK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	3450858	CHEMBL1244959	Binding affinity to RIPK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	3451134	CHEMBL1244959	Binding affinity to RIPK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	uM	10.0
	3603126	CHEMBL1291223	Inhibition of RIPK2 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	16.0	CHEMBL5014	Homo sapiens	Inihibition	%	16.0
	5120048	CHEMBL1648820	Inhibition of RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	1.0	CHEMBL5014	Homo sapiens	INH	%	1.0
	5120049	CHEMBL1648820	Inhibition of RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	1.0	CHEMBL5014	Homo sapiens	INH	%	1.0
	5120128	CHEMBL1648820	Inhibition of RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	6.0	CHEMBL5014	Homo sapiens	INH	%	6.0
	5120129	CHEMBL1648820	Inhibition of RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	6.0	CHEMBL5014	Homo sapiens	INH	%	6.0
	5120147	CHEMBL1648820	Inhibition of RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	8.0	CHEMBL5014	Homo sapiens	INH	%	8.0
	5120179	CHEMBL1648820	Inhibition of RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	13.0	CHEMBL5014	Homo sapiens	INH	%	13.0
	5121113	CHEMBL1648701	Inhibition of human RIPK2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	111.0	CHEMBL5014	Homo sapiens	INH	%	111.0
	5133697	CHEMBL1648715	Inhibition of RIPK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	79.0	CHEMBL5014	Homo sapiens	Activity	%	79.0
	5133792	CHEMBL1648715	Inhibition of RIPK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	82.0	CHEMBL5014	Homo sapiens	Activity	%	82.0
	5133879	CHEMBL1648715	Inhibition of RIPK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	66.0	CHEMBL5014	Homo sapiens	Activity	%	66.0
	5243762	CHEMBL1685866	Inhibition of RIPK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	94.0	CHEMBL5014	Homo sapiens	INH	%	94.0
	5243870	CHEMBL1686082	Inhibition of RIPK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	78.0	CHEMBL5014	Homo sapiens	INH	%	78.0
	5243983	CHEMBL1685866	Inhibition of RIPK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	87.0	CHEMBL5014	Homo sapiens	INH	%	87.0
	5244091	CHEMBL1686082	Inhibition of RIPK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	53.0	CHEMBL5014	Homo sapiens	INH	%	53.0
	5244964	CHEMBL1685866	Inhibition of RIPK2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	89.0	CHEMBL5014	Homo sapiens	INH	%	89.0
	5245072	CHEMBL1686082	Inhibition of RIPK2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	68.0	CHEMBL5014	Homo sapiens	INH	%	68.0
	5245223	CHEMBL1685866	Inhibition of RIPK2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	122.0	CHEMBL5014	Homo sapiens	INH	%	122.0
	5246053	CHEMBL1686082	Inhibition of RIPK2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	115.0	CHEMBL5014	Homo sapiens	INH	%	115.0
	5249450	CHEMBL1686801	Inhibition of RIPK2 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	13.0	CHEMBL5014	Homo sapiens	INH	%	13.0
	6221262	CHEMBL1787824	Inhibition of RIPK2 at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	4.0	CHEMBL5014	Homo sapiens	INH	%	4.0
	6325327	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	11.0	CHEMBL5014	Homo sapiens	INH	%	11.0
	6325357	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	24.0	CHEMBL5014	Homo sapiens	INH	%	24.0
	6325388	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	5.0	CHEMBL5014	Homo sapiens	INH	%	5.0
	6325421	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	0.0	CHEMBL5014	Homo sapiens	INH	%	0.0
	6325452	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	94.0	CHEMBL5014	Homo sapiens	INH	%	94.0
	6325482	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	11.0	CHEMBL5014	Homo sapiens	INH	%	11.0
	6325510	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	10.0	CHEMBL5014	Homo sapiens	INH	%	10.0
	6325540	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	2.0	CHEMBL5014	Homo sapiens	INH	%	2.0
	6325883	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	69.0	CHEMBL5014	Homo sapiens	INH	%	69.0
	6325913	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	0.0	CHEMBL5014	Homo sapiens	INH	%	0.0
	6325942	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	0.0	CHEMBL5014	Homo sapiens	INH	%	0.0
	6325971	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	7.0	CHEMBL5014	Homo sapiens	INH	%	7.0
	6326000	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	1.0	CHEMBL5014	Homo sapiens	INH	%	1.0
	6326029	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	0.0	CHEMBL5014	Homo sapiens	INH	%	0.0
	6326058	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	0.0	CHEMBL5014	Homo sapiens	INH	%	0.0
	6326087	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	7.0	CHEMBL5014	Homo sapiens	INH	%	7.0
	6326117	CHEMBL1820092	Inhibition of RIP2 expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by fluorescence polarization assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	6.0	CHEMBL5014	Homo sapiens	INH	%	6.0
	6341124	CHEMBL1826696	Activity of RIPK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	6352272	CHEMBL1826249	Inhibition of RIPK2 assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	57.0	CHEMBL5014	Homo sapiens	Activity	%	57.0
	6353479	CHEMBL1825791	Inhibition of RIPK2 at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	-7.0	CHEMBL5014	Homo sapiens	INH	%	-7.0
	7567322	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	98.0	CHEMBL5014	Homo sapiens	Kd	nM	98.0
	7567781	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7568278	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	16.0	CHEMBL5014	Homo sapiens	Kd	nM	16.0
	7568710	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7569295	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7569755	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	900.0	CHEMBL5014	Homo sapiens	Kd	nM	900.0
	7569785	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7570248	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7570675	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7571271	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7571762	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7572225	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7572641	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	9600.0	CHEMBL5014	Homo sapiens	Kd	nM	9600.0
	7573267	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	31.0	CHEMBL5014	Homo sapiens	Kd	nM	31.0
	7573743	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7574212	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7574620	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	500.0	CHEMBL5014	Homo sapiens	Kd	nM	500.0
	7574788	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7575249	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	680.0	CHEMBL5014	Homo sapiens	Kd	nM	680.0
	7575720	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	290.0	CHEMBL5014	Homo sapiens	Kd	nM	290.0
	7576185	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	430.0	CHEMBL5014	Homo sapiens	Kd	nM	430.0
	7576593	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	6100.0	CHEMBL5014	Homo sapiens	Kd	nM	6100.0
	7576762	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	2700.0	CHEMBL5014	Homo sapiens	Kd	nM	2700.0
	7577221	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	21.0	CHEMBL5014	Homo sapiens	Kd	nM	21.0
	7577699	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	3700.0	CHEMBL5014	Homo sapiens	Kd	nM	3700.0
	7578169	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	77.0	CHEMBL5014	Homo sapiens	Kd	nM	77.0
	7578574	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	4.6	CHEMBL5014	Homo sapiens	Kd	nM	4.6
	7578770	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7579144	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	5800.0	CHEMBL5014	Homo sapiens	Kd	nM	5800.0
	7579594	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7580068	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Kd	nM	3600.0	CHEMBL5014	Homo sapiens	Kd	nM	3600.0
	7581128	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7581513	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7581958	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	2500.0	CHEMBL5014	Homo sapiens	Kd	nM	2500.0
	7582429	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7582451	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7582851	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7583474	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7583871	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7584316	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7584807	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	970.0	CHEMBL5014	Homo sapiens	Kd	nM	970.0
	7585211	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7585804	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	2700.0	CHEMBL5014	Homo sapiens	Kd	nM	2700.0
	7586212	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	2900.0	CHEMBL5014	Homo sapiens	Kd	nM	2900.0
	7586687	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7587141	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7587765	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	9900.0	CHEMBL5014	Homo sapiens	Kd	nM	9900.0
	7588195	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	530.0	CHEMBL5014	Homo sapiens	Kd	nM	530.0
	7588666	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7589117	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	24.0	CHEMBL5014	Homo sapiens	Kd	nM	24.0
	7589712	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	640.0	CHEMBL5014	Homo sapiens	Kd	nM	640.0
	7590179	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7590653	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7591104	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7591261	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	9300.0	CHEMBL5014	Homo sapiens	Kd	nM	9300.0
	7591683	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7592155	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7592628	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7593081	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3700.0	CHEMBL5014	Homo sapiens	Kd	nM	3700.0
	7593228	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1100.0	CHEMBL5014	Homo sapiens	Kd	nM	1100.0
	7593663	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	950.0	CHEMBL5014	Homo sapiens	Kd	nM	950.0
	7594135	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7594608	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7595060	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1300.0	CHEMBL5014	Homo sapiens	Kd	nM	1300.0
	7595196	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7595640	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	300.0	CHEMBL5014	Homo sapiens	Kd	nM	300.0
	7596114	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7596585	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	580.0	CHEMBL5014	Homo sapiens	Kd	nM	580.0
	7597168	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1800.0	CHEMBL5014	Homo sapiens	Kd	nM	1800.0
	7597621	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7598094	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	7598564	CHEMBL1908622	Binding constant for RIPK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	5200.0	CHEMBL5014	Homo sapiens	Kd	nM	5200.0
	7931132	CHEMBL1919469	Inhibition of RIPK2 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	8.0	CHEMBL5014	Homo sapiens	INH	%	8.0
	7939956	CHEMBL1919625	Inhibition of human RIPK2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	7961145	CHEMBL1931554	Inhibition of RIPK2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	37000.0	CHEMBL5014	Homo sapiens	IC50	uM	37.0
	7961146	CHEMBL1931554	Inhibition of RIPK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	7969790	CHEMBL1930362	Inhibition of RIPK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	17.0	CHEMBL5014	Homo sapiens	Activity	%	17.0
	8047166	CHEMBL1959391	Inhibition of RIPK2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	10839534	CHEMBL2015804	Inhibition of RIPK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	59.0	CHEMBL5014	Homo sapiens	Activity	%	59.0
	10840424	CHEMBL2016328	Inhibition of RIPK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	94.0	CHEMBL5014	Homo sapiens	Activity	%	94.0
Active	12155960	CHEMBL2185156	Inhibition of RIPK2 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	12155962	CHEMBL2185156	Inhibition of RIPK2 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Activity	%	3.2	CHEMBL5014	Homo sapiens	Activity	%	3.2
	12170741	CHEMBL2209462	Inhibition of RIPK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	59.0	CHEMBL5014	Homo sapiens	Activity	%	59.0
	12170872	CHEMBL2213191	Inhibition of RIPK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	56.0	CHEMBL5014	Homo sapiens	Activity	%	56.0
	12172229	CHEMBL2212009	Inhibition of RIPK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	53.0	CHEMBL5014	Homo sapiens	Activity	%	53.0
	12183820	CHEMBL2214441	Inhibition of RIPK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	pIC50		5.0
	12264870	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	26.0	CHEMBL5014	Homo sapiens	Residual Activity	%	26.0
	12264871	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12264872	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	53.0	CHEMBL5014	Homo sapiens	Residual Activity	%	53.0
	12264873	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	99.0	CHEMBL5014	Homo sapiens	Residual Activity	%	99.0
	12264874	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	43.0	CHEMBL5014	Homo sapiens	Residual Activity	%	43.0
	12264875	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12264876	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	52.0	CHEMBL5014	Homo sapiens	Residual Activity	%	52.0
	12264877	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	26.0	CHEMBL5014	Homo sapiens	Residual Activity	%	26.0
	12264878	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12264879	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	26.0	CHEMBL5014	Homo sapiens	Residual Activity	%	26.0
	12264880	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12264881	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12264882	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	50.0	CHEMBL5014	Homo sapiens	Residual Activity	%	50.0
	12264883	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	27.0	CHEMBL5014	Homo sapiens	Residual Activity	%	27.0
	12264884	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	86.0	CHEMBL5014	Homo sapiens	Residual Activity	%	86.0
	12264885	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12264886	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12264887	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12264888	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	79.0	CHEMBL5014	Homo sapiens	Residual Activity	%	79.0
	12264889	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	18.0	CHEMBL5014	Homo sapiens	Residual Activity	%	18.0
	12264890	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12264891	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	76.0	CHEMBL5014	Homo sapiens	Residual Activity	%	76.0
	12264892	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL5014	Homo sapiens	Residual Activity	%	100.0
	12264893	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	104.0	CHEMBL5014	Homo sapiens	Residual Activity	%	104.0
	12264894	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12264895	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	24.0	CHEMBL5014	Homo sapiens	Residual Activity	%	24.0
	12264896	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	18.0	CHEMBL5014	Homo sapiens	Residual Activity	%	18.0
	12264897	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	20.0	CHEMBL5014	Homo sapiens	Residual Activity	%	20.0
	12264898	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12264899	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	78.0	CHEMBL5014	Homo sapiens	Residual Activity	%	78.0
	12264900	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	29.0	CHEMBL5014	Homo sapiens	Residual Activity	%	29.0
	12264901	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	21.0	CHEMBL5014	Homo sapiens	Residual Activity	%	21.0
	12264902	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	97.0	CHEMBL5014	Homo sapiens	Residual Activity	%	97.0
	12264903	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	86.0	CHEMBL5014	Homo sapiens	Residual Activity	%	86.0
	12264904	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12264905	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12264906	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	30.0	CHEMBL5014	Homo sapiens	Residual Activity	%	30.0
	12264907	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12264908	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	59.0	CHEMBL5014	Homo sapiens	Residual Activity	%	59.0
	12264909	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	100.0	CHEMBL5014	Homo sapiens	Residual Activity	%	100.0
	12264910	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	105.0	CHEMBL5014	Homo sapiens	Residual Activity	%	105.0
	12264911	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	95.0	CHEMBL5014	Homo sapiens	Residual Activity	%	95.0
	12264912	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	70.0	CHEMBL5014	Homo sapiens	Residual Activity	%	70.0
	12264913	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	30.0	CHEMBL5014	Homo sapiens	Residual Activity	%	30.0
	12264914	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	51.0	CHEMBL5014	Homo sapiens	Residual Activity	%	51.0
	12264915	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	87.0	CHEMBL5014	Homo sapiens	Residual Activity	%	87.0
	12264916	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	101.0	CHEMBL5014	Homo sapiens	Residual Activity	%	101.0
	12264917	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12264918	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	101.0	CHEMBL5014	Homo sapiens	Residual Activity	%	101.0
	12264919	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12264920	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12264921	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	21.0	CHEMBL5014	Homo sapiens	Residual Activity	%	21.0
	12264922	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	59.0	CHEMBL5014	Homo sapiens	Residual Activity	%	59.0
	12264923	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	95.0	CHEMBL5014	Homo sapiens	Residual Activity	%	95.0
	12264924	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	98.0	CHEMBL5014	Homo sapiens	Residual Activity	%	98.0
	12264925	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL5014	Homo sapiens	Residual Activity	%	99.0
	12264926	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	110.0	CHEMBL5014	Homo sapiens	Residual Activity	%	110.0
	12264927	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	100.0	CHEMBL5014	Homo sapiens	Residual Activity	%	100.0
	12264928	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	97.0	CHEMBL5014	Homo sapiens	Residual Activity	%	97.0
	12264929	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	95.0	CHEMBL5014	Homo sapiens	Residual Activity	%	95.0
	12264930	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	32.0	CHEMBL5014	Homo sapiens	Residual Activity	%	32.0
	12264931	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12264932	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL5014	Homo sapiens	Residual Activity	%	103.0
	12264933	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	99.0	CHEMBL5014	Homo sapiens	Residual Activity	%	99.0
	12264934	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12264935	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	103.0	CHEMBL5014	Homo sapiens	Residual Activity	%	103.0
	12264936	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12264937	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	97.0	CHEMBL5014	Homo sapiens	Residual Activity	%	97.0
	12264938	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	56.0	CHEMBL5014	Homo sapiens	Residual Activity	%	56.0
	12264939	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	28.0	CHEMBL5014	Homo sapiens	Residual Activity	%	28.0
	12264940	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	108.0	CHEMBL5014	Homo sapiens	Residual Activity	%	108.0
	12264941	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	69.0	CHEMBL5014	Homo sapiens	Residual Activity	%	69.0
	12264942	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	90.0	CHEMBL5014	Homo sapiens	Residual Activity	%	90.0
	12264943	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	52.0	CHEMBL5014	Homo sapiens	Residual Activity	%	52.0
	12264944	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	43.0	CHEMBL5014	Homo sapiens	Residual Activity	%	43.0
	12264945	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	99.0	CHEMBL5014	Homo sapiens	Residual Activity	%	99.0
	12264946	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	99.0	CHEMBL5014	Homo sapiens	Residual Activity	%	99.0
	12264947	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	62.0	CHEMBL5014	Homo sapiens	Residual Activity	%	62.0
	12264948	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	101.0	CHEMBL5014	Homo sapiens	Residual Activity	%	101.0
	12264949	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	49.0	CHEMBL5014	Homo sapiens	Residual Activity	%	49.0
	12264950	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL5014	Homo sapiens	Residual Activity	%	105.0
	12264951	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	62.0	CHEMBL5014	Homo sapiens	Residual Activity	%	62.0
	12264952	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12264953	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12264954	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12264955	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12264956	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	75.0	CHEMBL5014	Homo sapiens	Residual Activity	%	75.0
	12264957	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	24.0	CHEMBL5014	Homo sapiens	Residual Activity	%	24.0
	12264958	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12264959	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	60.0	CHEMBL5014	Homo sapiens	Residual Activity	%	60.0
	12264960	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12264961	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12264962	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	81.0	CHEMBL5014	Homo sapiens	Residual Activity	%	81.0
	12264963	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12264964	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	47.0	CHEMBL5014	Homo sapiens	Residual Activity	%	47.0
	12264965	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL5014	Homo sapiens	Residual Activity	%	105.0
	12264966	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12264967	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12264968	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	81.0	CHEMBL5014	Homo sapiens	Residual Activity	%	81.0
	12264969	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	87.0	CHEMBL5014	Homo sapiens	Residual Activity	%	87.0
	12264970	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	79.0	CHEMBL5014	Homo sapiens	Residual Activity	%	79.0
	12264971	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	5.0	CHEMBL5014	Homo sapiens	Residual Activity	%	5.0
	12264972	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12264973	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	105.0	CHEMBL5014	Homo sapiens	Residual Activity	%	105.0
	12264974	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	53.0	CHEMBL5014	Homo sapiens	Residual Activity	%	53.0
	12264975	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	69.0	CHEMBL5014	Homo sapiens	Residual Activity	%	69.0
	12264976	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	71.0	CHEMBL5014	Homo sapiens	Residual Activity	%	71.0
	12264977	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	90.0	CHEMBL5014	Homo sapiens	Residual Activity	%	90.0
	12264978	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12264979	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	49.0	CHEMBL5014	Homo sapiens	Residual Activity	%	49.0
	12264980	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	19.0	CHEMBL5014	Homo sapiens	Residual Activity	%	19.0
	12264981	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	58.0	CHEMBL5014	Homo sapiens	Residual Activity	%	58.0
	12264982	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	18.0	CHEMBL5014	Homo sapiens	Residual Activity	%	18.0
	12264983	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12264984	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12264985	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12264986	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	67.0	CHEMBL5014	Homo sapiens	Residual Activity	%	67.0
	12264987	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12264988	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	43.0	CHEMBL5014	Homo sapiens	Residual Activity	%	43.0
	12264989	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	65.0	CHEMBL5014	Homo sapiens	Residual Activity	%	65.0
	12264990	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	38.0	CHEMBL5014	Homo sapiens	Residual Activity	%	38.0
	12264991	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	75.0	CHEMBL5014	Homo sapiens	Residual Activity	%	75.0
	12264992	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	77.0	CHEMBL5014	Homo sapiens	Residual Activity	%	77.0
	12264993	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12264994	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	58.0	CHEMBL5014	Homo sapiens	Residual Activity	%	58.0
	12264995	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12264996	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12264997	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	107.0	CHEMBL5014	Homo sapiens	Residual Activity	%	107.0
	12264998	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	67.0	CHEMBL5014	Homo sapiens	Residual Activity	%	67.0
	12264999	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	16.0	CHEMBL5014	Homo sapiens	Residual Activity	%	16.0
	12265000	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12265001	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	79.0	CHEMBL5014	Homo sapiens	Residual Activity	%	79.0
	12265002	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	70.0	CHEMBL5014	Homo sapiens	Residual Activity	%	70.0
	12265003	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12265004	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	18.0	CHEMBL5014	Homo sapiens	Residual Activity	%	18.0
	12265005	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12266653	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12266654	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	74.0	CHEMBL5014	Homo sapiens	Residual Activity	%	74.0
	12266655	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	78.0	CHEMBL5014	Homo sapiens	Residual Activity	%	78.0
	12266656	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12266657	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12266658	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12266659	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12266660	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	14.0	CHEMBL5014	Homo sapiens	Residual Activity	%	14.0
	12266661	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	55.0	CHEMBL5014	Homo sapiens	Residual Activity	%	55.0
	12266662	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL5014	Homo sapiens	Residual Activity	%	90.0
	12266663	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12266664	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	65.0	CHEMBL5014	Homo sapiens	Residual Activity	%	65.0
	12266665	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	46.0	CHEMBL5014	Homo sapiens	Residual Activity	%	46.0
	12266666	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	102.0	CHEMBL5014	Homo sapiens	Residual Activity	%	102.0
	12266667	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	103.0	CHEMBL5014	Homo sapiens	Residual Activity	%	103.0
	12266668	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	100.0	CHEMBL5014	Homo sapiens	Residual Activity	%	100.0
	12266669	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL5014	Homo sapiens	Residual Activity	%	98.0
	12266670	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12266671	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	105.0	CHEMBL5014	Homo sapiens	Residual Activity	%	105.0
	12266672	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	102.0	CHEMBL5014	Homo sapiens	Residual Activity	%	102.0
	12266673	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	24.0	CHEMBL5014	Homo sapiens	Residual Activity	%	24.0
	12266674	CHEMBL2219149	Millipore: Percentage of residual kinase activity of RIPK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	100.0	CHEMBL5014	Homo sapiens	Residual Activity	%	100.0
	12266675	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	16.0	CHEMBL5014	Homo sapiens	Residual Activity	%	16.0
	12266676	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	74.0	CHEMBL5014	Homo sapiens	Residual Activity	%	74.0
	12266677	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	41.0	CHEMBL5014	Homo sapiens	Residual Activity	%	41.0
	12266678	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12266679	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	38.0	CHEMBL5014	Homo sapiens	Residual Activity	%	38.0
	12266680	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	67.0	CHEMBL5014	Homo sapiens	Residual Activity	%	67.0
	12266681	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	51.0	CHEMBL5014	Homo sapiens	Residual Activity	%	51.0
	12266682	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	16.0	CHEMBL5014	Homo sapiens	Residual Activity	%	16.0
	12266683	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	49.0	CHEMBL5014	Homo sapiens	Residual Activity	%	49.0
	12266684	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	20.0	CHEMBL5014	Homo sapiens	Residual Activity	%	20.0
	12266685	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	60.0	CHEMBL5014	Homo sapiens	Residual Activity	%	60.0
	12266686	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	68.0	CHEMBL5014	Homo sapiens	Residual Activity	%	68.0
	12266687	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	32.0	CHEMBL5014	Homo sapiens	Residual Activity	%	32.0
	12266688	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	17.0	CHEMBL5014	Homo sapiens	Residual Activity	%	17.0
	12266689	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	59.0	CHEMBL5014	Homo sapiens	Residual Activity	%	59.0
	12266690	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	99.0	CHEMBL5014	Homo sapiens	Residual Activity	%	99.0
	12266691	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266692	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266693	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	71.0	CHEMBL5014	Homo sapiens	Residual Activity	%	71.0
	12266694	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	20.0	CHEMBL5014	Homo sapiens	Residual Activity	%	20.0
	12266695	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12266696	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	42.0	CHEMBL5014	Homo sapiens	Residual Activity	%	42.0
	12266697	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266698	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	78.0	CHEMBL5014	Homo sapiens	Residual Activity	%	78.0
	12266699	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12266700	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	12.0	CHEMBL5014	Homo sapiens	Residual Activity	%	12.0
	12266701	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	6.0	CHEMBL5014	Homo sapiens	Residual Activity	%	6.0
	12266702	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	8.0	CHEMBL5014	Homo sapiens	Residual Activity	%	8.0
	12266703	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	70.0	CHEMBL5014	Homo sapiens	Residual Activity	%	70.0
	12266704	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	77.0	CHEMBL5014	Homo sapiens	Residual Activity	%	77.0
	12266705	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	16.0	CHEMBL5014	Homo sapiens	Residual Activity	%	16.0
	12266706	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	16.0	CHEMBL5014	Homo sapiens	Residual Activity	%	16.0
	12266707	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	64.0	CHEMBL5014	Homo sapiens	Residual Activity	%	64.0
	12266708	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266709	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	80.0	CHEMBL5014	Homo sapiens	Residual Activity	%	80.0
	12266710	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	79.0	CHEMBL5014	Homo sapiens	Residual Activity	%	79.0
	12266711	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	17.0	CHEMBL5014	Homo sapiens	Residual Activity	%	17.0
	12266712	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12266713	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	21.0	CHEMBL5014	Homo sapiens	Residual Activity	%	21.0
	12266714	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12266715	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12266716	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	81.0	CHEMBL5014	Homo sapiens	Residual Activity	%	81.0
	12266717	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	54.0	CHEMBL5014	Homo sapiens	Residual Activity	%	54.0
	12266718	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	7.0	CHEMBL5014	Homo sapiens	Residual Activity	%	7.0
	12266719	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	34.0	CHEMBL5014	Homo sapiens	Residual Activity	%	34.0
	12266720	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	59.0	CHEMBL5014	Homo sapiens	Residual Activity	%	59.0
	12266721	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12266722	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	94.0	CHEMBL5014	Homo sapiens	Residual Activity	%	94.0
	12266723	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	98.0	CHEMBL5014	Homo sapiens	Residual Activity	%	98.0
	12266724	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	86.0	CHEMBL5014	Homo sapiens	Residual Activity	%	86.0
	12266725	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	64.0	CHEMBL5014	Homo sapiens	Residual Activity	%	64.0
	12266726	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	15.0	CHEMBL5014	Homo sapiens	Residual Activity	%	15.0
	12266727	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	33.0	CHEMBL5014	Homo sapiens	Residual Activity	%	33.0
	12266728	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	76.0	CHEMBL5014	Homo sapiens	Residual Activity	%	76.0
	12266729	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266730	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12266731	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	77.0	CHEMBL5014	Homo sapiens	Residual Activity	%	77.0
	12266732	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	101.0	CHEMBL5014	Homo sapiens	Residual Activity	%	101.0
	12266733	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	64.0	CHEMBL5014	Homo sapiens	Residual Activity	%	64.0
	12266734	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	74.0	CHEMBL5014	Homo sapiens	Residual Activity	%	74.0
	12266735	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	25.0	CHEMBL5014	Homo sapiens	Residual Activity	%	25.0
	12266736	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	70.0	CHEMBL5014	Homo sapiens	Residual Activity	%	70.0
	12266737	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	64.0	CHEMBL5014	Homo sapiens	Residual Activity	%	64.0
	12266738	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	87.0	CHEMBL5014	Homo sapiens	Residual Activity	%	87.0
	12266739	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	56.0	CHEMBL5014	Homo sapiens	Residual Activity	%	56.0
	12266740	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266741	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12266742	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266743	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	21.0	CHEMBL5014	Homo sapiens	Residual Activity	%	21.0
	12266744	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	19.0	CHEMBL5014	Homo sapiens	Residual Activity	%	19.0
	12266745	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266746	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	71.0	CHEMBL5014	Homo sapiens	Residual Activity	%	71.0
	12266747	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	77.0	CHEMBL5014	Homo sapiens	Residual Activity	%	77.0
	12266748	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	46.0	CHEMBL5014	Homo sapiens	Residual Activity	%	46.0
	12266749	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	17.0	CHEMBL5014	Homo sapiens	Residual Activity	%	17.0
	12266750	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266751	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266752	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	27.0	CHEMBL5014	Homo sapiens	Residual Activity	%	27.0
	12266753	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	58.0	CHEMBL5014	Homo sapiens	Residual Activity	%	58.0
	12266754	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	12.0	CHEMBL5014	Homo sapiens	Residual Activity	%	12.0
	12266755	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266756	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	41.0	CHEMBL5014	Homo sapiens	Residual Activity	%	41.0
	12266757	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12266758	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266759	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL5014	Homo sapiens	Residual Activity	%	102.0
	12266760	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	95.0	CHEMBL5014	Homo sapiens	Residual Activity	%	95.0
	12266761	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	30.0	CHEMBL5014	Homo sapiens	Residual Activity	%	30.0
	12266762	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	21.0	CHEMBL5014	Homo sapiens	Residual Activity	%	21.0
	12266763	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12266764	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	27.0	CHEMBL5014	Homo sapiens	Residual Activity	%	27.0
	12266765	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	80.0	CHEMBL5014	Homo sapiens	Residual Activity	%	80.0
	12266766	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	78.0	CHEMBL5014	Homo sapiens	Residual Activity	%	78.0
	12266767	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	63.0	CHEMBL5014	Homo sapiens	Residual Activity	%	63.0
	12266768	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL5014	Homo sapiens	Residual Activity	%	93.0
	12266769	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	19.0	CHEMBL5014	Homo sapiens	Residual Activity	%	19.0
	12266770	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	113.0	CHEMBL5014	Homo sapiens	Residual Activity	%	113.0
	12266771	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	92.0	CHEMBL5014	Homo sapiens	Residual Activity	%	92.0
	12266772	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266773	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12266774	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12266775	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	72.0	CHEMBL5014	Homo sapiens	Residual Activity	%	72.0
	12266776	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL5014	Homo sapiens	Residual Activity	%	3.0
	12266777	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL5014	Homo sapiens	Residual Activity	%	106.0
	12266778	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	108.0	CHEMBL5014	Homo sapiens	Residual Activity	%	108.0
	12266779	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	23.0	CHEMBL5014	Homo sapiens	Residual Activity	%	23.0
	12266780	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	51.0	CHEMBL5014	Homo sapiens	Residual Activity	%	51.0
	12266781	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	60.0	CHEMBL5014	Homo sapiens	Residual Activity	%	60.0
	12266782	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266783	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266784	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	22.0	CHEMBL5014	Homo sapiens	Residual Activity	%	22.0
	12266785	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	25.0	CHEMBL5014	Homo sapiens	Residual Activity	%	25.0
	12266786	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	25.0	CHEMBL5014	Homo sapiens	Residual Activity	%	25.0
	12266787	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	10.0	CHEMBL5014	Homo sapiens	Residual Activity	%	10.0
	12266788	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	60.0	CHEMBL5014	Homo sapiens	Residual Activity	%	60.0
	12266789	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	66.0	CHEMBL5014	Homo sapiens	Residual Activity	%	66.0
	12266790	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	86.0	CHEMBL5014	Homo sapiens	Residual Activity	%	86.0
	12266791	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	29.0	CHEMBL5014	Homo sapiens	Residual Activity	%	29.0
	12266792	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	91.0	CHEMBL5014	Homo sapiens	Residual Activity	%	91.0
	12266793	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	16.0	CHEMBL5014	Homo sapiens	Residual Activity	%	16.0
	12266794	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	24.0	CHEMBL5014	Homo sapiens	Residual Activity	%	24.0
	12266795	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	30.0	CHEMBL5014	Homo sapiens	Residual Activity	%	30.0
	12266796	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	49.0	CHEMBL5014	Homo sapiens	Residual Activity	%	49.0
	12266797	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	68.0	CHEMBL5014	Homo sapiens	Residual Activity	%	68.0
	12266798	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	78.0	CHEMBL5014	Homo sapiens	Residual Activity	%	78.0
	12266799	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	50.0	CHEMBL5014	Homo sapiens	Residual Activity	%	50.0
	12266800	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12266801	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12266802	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12266803	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266804	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	29.0	CHEMBL5014	Homo sapiens	Residual Activity	%	29.0
	12266805	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	78.0	CHEMBL5014	Homo sapiens	Residual Activity	%	78.0
	12266806	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	81.0	CHEMBL5014	Homo sapiens	Residual Activity	%	81.0
	12266807	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	52.0	CHEMBL5014	Homo sapiens	Residual Activity	%	52.0
	12266808	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	95.0	CHEMBL5014	Homo sapiens	Residual Activity	%	95.0
	12266809	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	11.0	CHEMBL5014	Homo sapiens	Residual Activity	%	11.0
	12266810	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	77.0	CHEMBL5014	Homo sapiens	Residual Activity	%	77.0
	12266811	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266812	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	41.0	CHEMBL5014	Homo sapiens	Residual Activity	%	41.0
	12266813	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	85.0	CHEMBL5014	Homo sapiens	Residual Activity	%	85.0
	12266814	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	89.0	CHEMBL5014	Homo sapiens	Residual Activity	%	89.0
	12266815	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL5014	Homo sapiens	Residual Activity	%	98.0
	12266816	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	95.0	CHEMBL5014	Homo sapiens	Residual Activity	%	95.0
	12266817	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266818	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	7.0	CHEMBL5014	Homo sapiens	Residual Activity	%	7.0
	12266819	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	18.0	CHEMBL5014	Homo sapiens	Residual Activity	%	18.0
	12266820	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266821	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	84.0	CHEMBL5014	Homo sapiens	Residual Activity	%	84.0
	12266822	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	32.0	CHEMBL5014	Homo sapiens	Residual Activity	%	32.0
	12266823	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	21.0	CHEMBL5014	Homo sapiens	Residual Activity	%	21.0
	12266824	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	82.0	CHEMBL5014	Homo sapiens	Residual Activity	%	82.0
	12266825	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	57.0	CHEMBL5014	Homo sapiens	Residual Activity	%	57.0
	12266826	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266827	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	83.0	CHEMBL5014	Homo sapiens	Residual Activity	%	83.0
	12266828	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	87.0	CHEMBL5014	Homo sapiens	Residual Activity	%	87.0
	12266829	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL5014	Homo sapiens	Residual Activity	%	100.0
	12266830	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	88.0	CHEMBL5014	Homo sapiens	Residual Activity	%	88.0
	12266831	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	14.0	CHEMBL5014	Homo sapiens	Residual Activity	%	14.0
	12266832	CHEMBL2219150	Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	96.0	CHEMBL5014	Homo sapiens	Residual Activity	%	96.0
	12668233	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	44.0	CHEMBL5014	Homo sapiens	INH	%	44.0
	12668234	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	98.0	CHEMBL5014	Homo sapiens	INH	%	98.0
	12668235	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	91.0	CHEMBL5014	Homo sapiens	INH	%	91.0
	12668236	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	76.0	CHEMBL5014	Homo sapiens	INH	%	76.0
	12668237	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	15.0	CHEMBL5014	Homo sapiens	INH	%	15.0
	12668238	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	28.0	CHEMBL5014	Homo sapiens	INH	%	28.0
	12668239	CHEMBL2345059	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	52.0	CHEMBL5014	Homo sapiens	INH	%	52.0
	12672907	CHEMBL2341621	Inhibition of recombinant RIPK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	76.0	CHEMBL5014	Homo sapiens	Activity	%	76.0
	12672908	CHEMBL2341621	Inhibition of recombinant RIPK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	72.0	CHEMBL5014	Homo sapiens	Activity	%	72.0
	12674229	CHEMBL2344632	Inhibition of human RIPK2 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	12.0	CHEMBL5014	Homo sapiens	Activity	%	12.0
	12693175	CHEMBL2345776	Inhibition of RIPK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	nM	10000.0
	12723641	CHEMBL2350471	Inhibition of RIPK2 (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	56.0	CHEMBL5014	Homo sapiens	INH	%	56.0
	12723686	CHEMBL2350779	Inhibition of RIPK2 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	77.0	CHEMBL5014	Homo sapiens	INH	%	77.0
	12723687	CHEMBL2350779	Inhibition of RIPK2 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	17.0	CHEMBL5014	Homo sapiens	INH	%	17.0
	12729834	CHEMBL2352166	Inhibition of RIPK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	91.0	CHEMBL5014	Homo sapiens	Activity	%	91.0
	13374361	CHEMBL2406305	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	17.0	CHEMBL5014	Homo sapiens	INH	%	17.0
	13439931	CHEMBL2429474	Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	13445441	CHEMBL2429474	Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	13448496	CHEMBL2429474	Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	13448632	CHEMBL2429474	Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	13451427	CHEMBL2429474	Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	13454612	CHEMBL2429474	Competitive binding affinity to RIPK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	66.0	CHEMBL5014	Homo sapiens	INH	%	66.0
	13871759	CHEMBL3100924	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	85.0	CHEMBL5014	Homo sapiens	Activity	%	85.0
	14585317	CHEMBL3241833	Inhibition of human RIPK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	98.0	CHEMBL5014	Homo sapiens	Activity	%	98.0
	14659716	CHEMBL3269189	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	81.0	CHEMBL5014	Homo sapiens	Activity	%	81.0
	14659717	CHEMBL3269190	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	31.0	CHEMBL5014	Homo sapiens	Activity	%	31.0
	14659718	CHEMBL3269191	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	7.0	CHEMBL5014	Homo sapiens	Activity	%	7.0
	14659719	CHEMBL3269192	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	3.0	CHEMBL5014	Homo sapiens	Activity	%	3.0
	14659740	CHEMBL3270794	Inhibition of RIPK2 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	IC50	nM	54.0	CHEMBL5014	Homo sapiens	IC50	uM	0.054
	14659741	CHEMBL3270794	Inhibition of RIPK2 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	IC50	nM	685.0	CHEMBL5014	Homo sapiens	IC50	uM	0.685
	14659742	CHEMBL3270794	Inhibition of RIPK2 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3nccnc3c2)n1		CHEMBL492634	=	IC50	nM	111.0	CHEMBL5014	Homo sapiens	IC50	uM	0.111
	14659743	CHEMBL3270794	Inhibition of RIPK2 (unknown origin) by radioisotopic assay	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	IC50	nM	44.0	CHEMBL5014	Homo sapiens	IC50	uM	0.044
	14664308	CHEMBL3271262	Inhibition of RIPK2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	99.0	CHEMBL5014	Homo sapiens	INH	%	99.0
	14664309	CHEMBL3271262	Inhibition of RIPK2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	82.0	CHEMBL5014	Homo sapiens	INH	%	82.0
	14664310	CHEMBL3271262	Inhibition of RIPK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	96.0	CHEMBL5014	Homo sapiens	INH	%	96.0
Not Active	14999359	CHEMBL3368450	Inhibition of human RIPK2 at 10 uM relative to control	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2ccc(O)cc2)C1		CHEMBL3323314		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	15055354	CHEMBL3380486	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	9.0	CHEMBL5014	Homo sapiens	Activity	%	9.0
	15072581	CHEMBL3388689	Inhibition of RIPK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	106.0	CHEMBL5014	Homo sapiens	Activity	%	106.0
	15112143	CHEMBL3388155	Inhibition of RIPK2 (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	=	IC50	nM	50978.0	CHEMBL5014	Homo sapiens	IC50	nM	50978.0
	15251881	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	53.0	CHEMBL5014	Homo sapiens	Activity	%	53.0
	15251916	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	27.0	CHEMBL5014	Homo sapiens	Activity	%	27.0
	15252018	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	52.0	CHEMBL5014	Homo sapiens	Activity	%	52.0
	15252663	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	75.0	CHEMBL5014	Homo sapiens	Activity	%	75.0
	15252765	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	88.0	CHEMBL5014	Homo sapiens	Activity	%	88.0
	15252867	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	92.0	CHEMBL5014	Homo sapiens	Activity	%	92.0
	15253541	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	64.0	CHEMBL5014	Homo sapiens	Activity	%	64.0
	15253643	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	72.0	CHEMBL5014	Homo sapiens	Activity	%	72.0
	15253745	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	61.0	CHEMBL5014	Homo sapiens	Activity	%	61.0
	15254411	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	60.0	CHEMBL5014	Homo sapiens	Activity	%	60.0
	15254513	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	52.0	CHEMBL5014	Homo sapiens	Activity	%	52.0
	15254615	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	24.0	CHEMBL5014	Homo sapiens	Activity	%	24.0
	15255306	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	59.0	CHEMBL5014	Homo sapiens	Activity	%	59.0
	15255408	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	66.0	CHEMBL5014	Homo sapiens	Activity	%	66.0
	15255511	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	42.0	CHEMBL5014	Homo sapiens	Activity	%	42.0
	15256242	CHEMBL3427821	Inhibition of RIPK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	30.0	CHEMBL5014	Homo sapiens	Activity	%	30.0
	15637794	CHEMBL3591474	Inhibition of RIPK2 (unknown origin) at 1 uM preincubated for 5 mins with enzyme and substrate followed by ATP addition relative to control	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590222	=	Inhibition	%	60.0	CHEMBL5014	Homo sapiens	INH	%	60.0
	15686152	CHEMBL3606892	Inhibition of RIPK2 (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL5014	Homo sapiens	INH	%	80.0
	15756123	CHEMBL3631916	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as residence time by by fluorescent polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	T1/2	hr	1.417	CHEMBL5014	Homo sapiens	t1/2	min	85.0
	15756124	CHEMBL3631917	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as dissociation rate by fluorescent polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Non standard unit for type	CHEMBL166031	=	K	/s	0.000135	CHEMBL5014	Homo sapiens	K	/s	0.000135
	15756125	CHEMBL3631915	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as reduction in autophosphorylation pre-incubated for 30 mins followed by incubation with ATP for 2 hrs by ADP-Glo assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	IC50	nM	63.0	CHEMBL5014	Homo sapiens	IC50	nM	63.0
	15756126	CHEMBL3631914	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells by fluorescent polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	IC50	nM	320.0	CHEMBL5014	Homo sapiens	IC50	nM	320.0
	15757718	CHEMBL3631916	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as residence time by by fluorescent polarization assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	T1/2	hr	0.006667	CHEMBL5014	Homo sapiens	t1/2	min	0.4
	15757719	CHEMBL3631917	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as dissociation rate by fluorescent polarization assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1	Non standard unit for type	CHEMBL10	=	K	/s	0.0317	CHEMBL5014	Homo sapiens	K	/s	0.0317
	15757720	CHEMBL3631915	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as reduction in autophosphorylation pre-incubated for 30 mins followed by incubation with ATP for 2 hrs by ADP-Glo assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	15757721	CHEMBL3631914	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells by fluorescent polarization assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	200.0	CHEMBL5014	Homo sapiens	IC50	nM	200.0
	15757973	CHEMBL3631914	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells by fluorescent polarization assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	IC50	nM	7.9	CHEMBL5014	Homo sapiens	IC50	nM	7.9
	15757974	CHEMBL3631915	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as reduction in autophosphorylation pre-incubated for 30 mins followed by incubation with ATP for 2 hrs by ADP-Glo assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	IC50	nM	6.3	CHEMBL5014	Homo sapiens	IC50	nM	6.3
	15757975	CHEMBL3631917	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as dissociation rate by fluorescent polarization assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1	Non standard unit for type	CHEMBL3628627	=	K	/s	0.000147	CHEMBL5014	Homo sapiens	K	/s	0.000147
	15757976	CHEMBL3631916	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as residence time by by fluorescent polarization assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	T1/2	hr	1.317	CHEMBL5014	Homo sapiens	t1/2	min	79.0
	15759685	CHEMBL3631914	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells by fluorescent polarization assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	IC50	nM	500.0	CHEMBL5014	Homo sapiens	IC50	nM	500.0
	15759686	CHEMBL3631915	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as reduction in autophosphorylation pre-incubated for 30 mins followed by incubation with ATP for 2 hrs by ADP-Glo assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	IC50	nM	12.0	CHEMBL5014	Homo sapiens	IC50	nM	12.0
	15759687	CHEMBL3631917	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as dissociation rate by fluorescent polarization assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Non standard unit for type	CHEMBL3628628	=	K	/s	0.12	CHEMBL5014	Homo sapiens	K	/s	0.12
	15759688	CHEMBL3631916	Inhibition of full-length FLAG-6His-TEV tagged human RIP2 expressed in Sf9 cells assessed as residence time by by fluorescent polarization assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	T1/2	hr	0.001667	CHEMBL5014	Homo sapiens	t1/2	min	0.1
	16425277	CHEMBL3751107	Inhibition of RIPK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-0.4	CHEMBL5014	Homo sapiens	INH	%	-0.4
	16431988	CHEMBL3750027	Inhibition of human RIPK2 using MBP substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	16451596	CHEMBL3761177	Inhibition of RIPK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	97.2	CHEMBL5014	Homo sapiens	INH	%	97.2
	16495209	CHEMBL3777751	Inhibition of N-terminal His6-tagged recombinant human RIPK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-16.0	CHEMBL5014	Homo sapiens	Activity	%	-16.0
	16496128	CHEMBL3777751	Inhibition of N-terminal His6-tagged recombinant human RIPK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-16.0	CHEMBL5014	Homo sapiens	Activity	%	-16.0
Not Active	16497491	CHEMBL3777934	Inhibition of human RIPK2 (2 to 311 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	16506512	CHEMBL3776506	Inhibition of recombinant human His-tagged RIPK2 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	83.0	CHEMBL5014	Homo sapiens	INH	%	83.0
	16507183	CHEMBL3778993	Inhibition of recombinant RIPK2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	16508918	CHEMBL3777751	Inhibition of N-terminal His6-tagged recombinant human RIPK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-9.0	CHEMBL5014	Homo sapiens	Activity	%	-9.0
Active	16595031	CHEMBL3812740	Inhibition of RIPK2 (unknown origin) at 10 uM	B	Cc1nn(-c2ccccc2)c2nc(CNc3ccc(O)cc3)n(C)c(=O)c12		CHEMBL3808883		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	16612695	CHEMBL3815726	Inhibition of human RIPK2 (2 to 311 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-13.0	CHEMBL5014	Homo sapiens	Activity	%	-13.0
	16614616	CHEMBL3816762	Inhibition of human RIPK2 at 1 uM using MBP substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	61.0	CHEMBL5014	Homo sapiens	INH	%	61.0
	16638297	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	IC50	nM	3.162	CHEMBL5014	Homo sapiens	pIC50		8.5
	16638298	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	251.19	CHEMBL5014	Homo sapiens	pIC50		6.6
	16638299	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3822979	=	IC50	nM	794.33	CHEMBL5014	Homo sapiens	pIC50		6.1
	16638300	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3822979	=	IC50	nM	790.0	CHEMBL5014	Homo sapiens	IC50	nM	790.0
	16638301	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	250.0	CHEMBL5014	Homo sapiens	IC50	nM	250.0
	16638302	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	IC50	nM	3.0	CHEMBL5014	Homo sapiens	IC50	nM	3.0
	16638303	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CS(=O)(=O)c1ccc2nccc(Nc3ccc4[nH]nnc4c3)c2c1		CHEMBL3823809	=	IC50	nM	50.0	CHEMBL5014	Homo sapiens	IC50	nM	50.0
	16638304	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CS(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1		CHEMBL3822791	=	IC50	nM	6.3	CHEMBL5014	Homo sapiens	IC50	nM	6.3
	16638305	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CS(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3822754	=	IC50	nM	50.0	CHEMBL5014	Homo sapiens	IC50	nM	50.0
	16638306	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	Cc1ccc(O)cc1Nc1ccnc2ccccc12		CHEMBL3822573	=	IC50	nM	630.0	CHEMBL5014	Homo sapiens	IC50	nM	630.0
	16638307	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	Cc1ccc(O)cc1Nc1ccnc2ccc(-c3cccnc3)cc12		CHEMBL237345	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	16638308	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	Cc1ccc(O)cc1Nc1ccnc2ccc(C(=O)NCC3CCOCC3)cc12		CHEMBL3824056	=	IC50	nM	20.0	CHEMBL5014	Homo sapiens	IC50	nM	20.0
	16638309	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	COc1ccc2nccc(Nc3cc(O)ccc3C)c2c1		CHEMBL3823527	=	IC50	nM	250.0	CHEMBL5014	Homo sapiens	IC50	nM	250.0
	16638310	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	Cc1ccc(O)cc1Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL3822938	=	IC50	nM	8.0	CHEMBL5014	Homo sapiens	IC50	nM	8.0
	16638311	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CC(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3822577	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	16638312	CHEMBL3825637	Competitive inhibition of full length FLAG-His-tagged RIP2K (unknown origin) expressed in baculovirus expression system preincubated for 10 mins followed by addition of fluorescent-labeled 2-Methyl-5-(2-propen-l-yloxy)aniline measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	nM	5.0
	16638313	CHEMBL3825638	Inhibition of RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion	B	CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3822979	=	IC50	nM	320.0	CHEMBL5014	Homo sapiens	IC50	nM	320.0
	16638314	CHEMBL3825638	Inhibition of RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	250.0	CHEMBL5014	Homo sapiens	IC50	nM	250.0
	16638315	CHEMBL3825638	Inhibition of RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	IC50	nM	20.0	CHEMBL5014	Homo sapiens	IC50	nM	20.0
	16638316	CHEMBL3825638	Inhibition of RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	18.0	CHEMBL5014	Homo sapiens	IC50	nM	18.0
	16638317	CHEMBL3825639	Inhibition of RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3822979	=	IC50	nM	2000.0	CHEMBL5014	Homo sapiens	IC50	nM	2000.0
	16638318	CHEMBL3825639	Inhibition of RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	6310.0	CHEMBL5014	Homo sapiens	IC50	nM	6310.0
	16638319	CHEMBL3825639	Inhibition of RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	nM	10000.0
	16638320	CHEMBL3825639	Inhibition of RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	nM	10000.0
	16638321	CHEMBL3825640	Selectivity ratio, ratio of IC50 for RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion to IC50 for RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	CNc1cc(Oc2c(F)cc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2F)ccn1		CHEMBL3822979	=	Ratio IC50		6.2	CHEMBL5014	Homo sapiens	Ratio IC50		6.2
	16638322	CHEMBL3825640	Selectivity ratio, ratio of IC50 for RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion to IC50 for RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ratio IC50		25.0	CHEMBL5014	Homo sapiens	Ratio IC50		25.0
	16638323	CHEMBL3825640	Selectivity ratio, ratio of IC50 for RIP2K in MDP-stimulated HEK-293 cells over-expressing NOD2 assessed as IL8 secretion to IC50 for RIP2K in Pam2CSK4-stimulated HEK-293 cells over-expressing TLR2 assessed as IL8 secretion	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	>	Ratio IC50		500.0	CHEMBL5014	Homo sapiens	Ratio IC50		500.0
	16638358	CHEMBL3825647	Inhibition of human full length N-terminal GST-tagged RIP2K expressed in baculovirus expression system at 1 uM	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	16654232	CHEMBL3829765	Inhibition of human RIPK2 (2 to 311 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	63.0	CHEMBL5014	Homo sapiens	Activity	%	63.0
421767	17784826	CHEMBL3888892	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl		CHEMBL2011291	=	IC50	nM	41.0	CHEMBL5014	Homo sapiens	IC50	nM	41.0
421783	17784842	CHEMBL3888892	"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac)."	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	3.8	CHEMBL5014	Homo sapiens	IC50	nM	3.8
Inactive	17935252	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935253	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935254	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935255	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3292.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	3292.0
Inactive	17935256	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935257	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935258	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935259	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	57.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	57.0
Inactive	17935260	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935261	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	48.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	48.0
Inactive	17935262	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935263	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935264	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935265	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	Kd	nM	1090.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1090.0
Inactive	17935266	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935267	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	54.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	54.0
Inactive	17935268	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935269	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935270	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935271	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935272	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	611.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	611.0
Inactive	17935273	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935274	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935275	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935276	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	178.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	178.0
Inactive	17935277	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935278	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935279	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935280	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	=	Kd	nM	988.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	988.0
Inactive	17935281	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935282	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935283	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935284	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935285	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935286	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935287	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935288	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935289	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935290	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935291	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935292	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935293	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935294	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	751.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	751.0
Inactive	17935295	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935296	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	482.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	482.0
Inactive	17935297	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935298	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935299	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935300	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935301	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935302	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935303	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935304	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935305	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935306	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	192.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	192.0
Inactive	17935307	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935308	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935309	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935310	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935311	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935312	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935313	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935314	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935315	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935316	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935317	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935318	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	=	Kd	nM	427.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	427.0
Inactive	17935319	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935320	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935321	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	7665.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	7665.0
Inactive	17935322	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935323	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935324	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935325	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935326	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935327	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	526.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	526.0
Inactive	17935328	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935329	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935330	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935331	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935332	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935333	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	1312.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1312.0
Inactive	17935334	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935335	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935336	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935337	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935338	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935339	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	442.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	442.0
Inactive	17935340	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935341	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935342	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	903.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	903.0
Inactive	17935343	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935344	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935345	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935346	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935347	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935348	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935349	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935350	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	11.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	11.0
Inactive	17935351	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935352	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935353	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935354	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935355	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	355.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	355.0
Inactive	17935356	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935357	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935358	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935359	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935360	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935361	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935362	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935363	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935364	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935365	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935366	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935367	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	106.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	106.0
Inactive	17935368	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935369	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935370	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935371	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	767.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	767.0
Inactive	17935372	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935373	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935374	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	=	Kd	nM	1163.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1163.0
Inactive	17935375	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935376	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	1850.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1850.0
Inactive	17935377	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935378	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	20.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	20.0
Inactive	17935379	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935380	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935381	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935382	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935383	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935384	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935385	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935386	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935387	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935388	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935389	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935390	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935391	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Kd	nM	767.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	767.0
Active	17935392	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	Kd	nM	199.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	199.0
Inactive	17935393	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935394	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935395	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935396	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935397	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935398	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935399	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	679.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	679.0
Inactive	17935400	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935401	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935402	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935403	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935404	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	83.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	83.0
Inactive	17935405	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935406	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	74.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	74.0
Inactive	17935407	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935408	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	1364.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1364.0
Inactive	17935409	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935410	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935411	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935412	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935413	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935414	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935415	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935416	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935417	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935418	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	7.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	7.0
Inactive	17935419	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935420	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	958.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	958.0
Inactive	17935421	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935422	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935423	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935424	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	11433.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	11433.0
Inactive	17935425	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935426	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935427	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935428	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935429	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935430	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935431	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935432	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935433	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935434	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935435	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935436	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	5.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	5.0
Inactive	17935437	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935438	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935439	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935440	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935441	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935442	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935443	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935444	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	1469.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1469.0
Inactive	17935445	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935446	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	Kd	nM	5939.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	5939.0
Active	17935447	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	33.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	33.0
Inactive	17935448	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935449	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935450	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935451	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	0.9	CHEMBL5014	Homo sapiens	Kd apparent	nM	0.9
Inactive	17935452	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935453	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935454	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935455	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935456	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935457	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935458	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935459	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935460	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935461	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935462	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	Kd	nM	323.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	323.0
Active	17935463	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	=	Kd	nM	390.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	390.0
Active	17935464	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	=	Kd	nM	810.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	810.0
Inactive	17935465	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935466	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	2.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	2.0
Inactive	17935467	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935468	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935469	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935470	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	=	Kd	nM	2627.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	2627.0
Inactive	17935471	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935472	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935473	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935474	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935475	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17935476	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	1967.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	1967.0
Inactive	17935477	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935478	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935479	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935480	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935481	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	38.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	38.0
Inactive	17935482	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935483	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	97.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	97.0
Inactive	17935484	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Active	17935485	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	801.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	801.0
Inactive	17935486	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935487	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935488	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935489	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935490	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935491	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935492	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935493	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17935494	CHEMBL3991868	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5014	Homo sapiens	Kd apparent	nM	30000.0
Not Active	17955946	CHEMBL3993606	Inhibition of recombinant human N-terminal GST-tagged RIP2 (1 to 299 residues) expressed in baculovirus infected Sf9 cells at 10 uM using MBP as substrate incubated for 60 mins in presence of ATP by ADP-Glo assay	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](OCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)/C=C/c3ccc(Cl)cc3)C(N)=O)C(N)=O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL4078846		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	18048605	CHEMBL4011058	Inhibition of TNFalpha-stimulated RIPK2 in human U937 cells assessed as residual activity at 10 uM in presence of ATP relative to control	B	S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4088718	=	Activity	%	54.0	CHEMBL5014	Homo sapiens	Activity	%	54.0
	18048609	CHEMBL4011062	Inhibition of TNFalpha-stimulated RIPK2 in human U937 cells in presence of 5 uM ATP	B	S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4088718	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18048735	CHEMBL4011081	Inhibition of RIPK2 (unknown origin) at 0.5 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	46.0	CHEMBL5014	Homo sapiens	INH	%	46.0
Not Active	18077105	CHEMBL4016501	Inhibition of recombinant human N-terminal GST tagged RIPK2 (1 to 299 residues) expressed in baculovirus infected Sf9 insect cells assessed as decrease in MBP phosphorylation at 10 uM preincubated with compound followed by ATP addition measured after 60 mins by ADP-Glo assay	B	CCCNC(=O)CC[C@H]1NC(=O)c2cc(Oc3cccc(N(C)C)c3)c(NC(=O)COCc3ccccc3)cc2NC1=O		CHEMBL4068672		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	18114832	CHEMBL4025362	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	62.0	CHEMBL5014	Homo sapiens	Activity	%	62.0
	18138936	CHEMBL4030447	Inhibition of RIPK2 (unknown origin) at 10 uM relative to control	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	Inhibition	%	33.0	CHEMBL5014	Homo sapiens	INH	%	33.0
	18203886	CHEMBL4044173	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	18225232	CHEMBL4048696	Inhibition of RIPK2 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCCC2)NC3=O)ncn1		CHEMBL4076439	=	Inhibition	%	59.0	CHEMBL5014	Homo sapiens	INH	%	59.0
	18232201	CHEMBL4050305	Inhibition of human RIPK2 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	39.0	CHEMBL5014	Homo sapiens	Activity	%	39.0
	18253644	CHEMBL4055106	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	93.0	CHEMBL5014	Homo sapiens	Activity	%	93.0
	18253645	CHEMBL4055106	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	18269009	CHEMBL4058139	Inhibition of recombinant human N-terminal His6-tagged RIPK2 (1 to 299 residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	403.1	CHEMBL5014	Homo sapiens	IC50	nM	403.1
	18282207	CHEMBL4120162	Inhibition of recombinant His-tagged human RIPK2 catalytic domain (1 to 299 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	34.2	CHEMBL5014	Homo sapiens	INH	%	34.2
	18282526	CHEMBL4120162	Inhibition of recombinant His-tagged human RIPK2 catalytic domain (1 to 299 residues) expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	41.4	CHEMBL5014	Homo sapiens	INH	%	41.4
	18327452	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	O=C(Nc1ccccc1Cl)c1cnn2ccccc12		CHEMBL1078785	=	IC50	nM	1500.0	CHEMBL5014	Homo sapiens	IC50	uM	1.5
	18327453	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(C(=O)Nc3ccccc3C)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4162913	=	IC50	nM	24.0	CHEMBL5014	Homo sapiens	IC50	uM	0.024
	18327454	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(C(=O)Oc3ccccc3C)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4170854	=	IC50	nM	38.0	CHEMBL5014	Homo sapiens	IC50	uM	0.038
	18327455	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cccc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4166371	=	IC50	nM	90.0	CHEMBL5014	Homo sapiens	IC50	uM	0.09
	18327456	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccccc3Cl)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4174288	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18327457	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc(Cl)cc3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4164029	=	IC50	nM	520.0	CHEMBL5014	Homo sapiens	IC50	uM	0.52
	18327458	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1ccccc1-c1cnc2cc(OC)c(S(=O)(=O)C(C)(C)C)cn12		CHEMBL4170760	=	IC50	nM	460.0	CHEMBL5014	Homo sapiens	IC50	uM	0.46
	18327459	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cccc(-c2cnc3cc(OC)c(S(=O)(=O)C(C)(C)C)cn23)c1		CHEMBL4160116	=	IC50	nM	40.0	CHEMBL5014	Homo sapiens	IC50	uM	0.04
	18327460	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1ccc(-c2cnc3cc(OC)c(S(=O)(=O)C(C)(C)C)cn23)cc1		CHEMBL4167365	=	IC50	nM	130.0	CHEMBL5014	Homo sapiens	IC50	uM	0.13
	18327461	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccccc3C(N)=O)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4175235	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18327462	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cccc(C(N)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4159032	=	IC50	nM	430.0	CHEMBL5014	Homo sapiens	IC50	uM	0.43
	18327463	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc(C(N)=O)cc3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4166930	=	IC50	nM	160.0	CHEMBL5014	Homo sapiens	IC50	uM	0.16
	18327464	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cccc(O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4174187	=	IC50	nM	35.0	CHEMBL5014	Homo sapiens	IC50	uM	0.035
	18327465	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc(O)cc3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4163484	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	uM	0.016
	18327466	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cccc(C#N)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4175635	=	IC50	nM	180.0	CHEMBL5014	Homo sapiens	IC50	uM	0.18
	18327467	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc(C(N)=O)c(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4165019	=	IC50	nM	70.0	CHEMBL5014	Homo sapiens	IC50	uM	0.07
	18327468	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc(-c2cnc3cc(OC)c(S(=O)(=O)C(C)(C)C)cn23)ccc1O		CHEMBL4168738	=	IC50	nM	11.0	CHEMBL5014	Homo sapiens	IC50	uM	0.011
	18327469	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc(O)c(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4160817	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	uM	0.005
	18327470	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc(Cl)cc(-c2cnc3cc(OC)c(S(=O)(=O)C(C)(C)C)cn23)c1		CHEMBL4172092	=	IC50	nM	45.0	CHEMBL5014	Homo sapiens	IC50	uM	0.045
	18327471	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cc(O)cc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4164217	=	IC50	nM	9.0	CHEMBL5014	Homo sapiens	IC50	uM	0.009
	18327472	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc4cn[nH]c4c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4175533	=	IC50	nM	200.0	CHEMBL5014	Homo sapiens	IC50	uM	0.2
	18327473	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc4[nH]ncc4c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4167668	=	IC50	nM	20.0	CHEMBL5014	Homo sapiens	IC50	uM	0.02
	18327474	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccc4nc[nH]c4c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4160433	=	IC50	nM	120.0	CHEMBL5014	Homo sapiens	IC50	uM	0.12
	18327475	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cccc(NC(C)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4171039	=	IC50	nM	21.0	CHEMBL5014	Homo sapiens	IC50	uM	0.021
	18327476	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccnc(N)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4173646	=	IC50	nM	29.0	CHEMBL5014	Homo sapiens	IC50	uM	0.029
	18327477	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3ccnc(NC(C)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4165728	=	IC50	nM	60.0	CHEMBL5014	Homo sapiens	IC50	uM	0.06
	18327478	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cc(Cl)cc(NC(C)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4176853	=	IC50	nM	2.0	CHEMBL5014	Homo sapiens	IC50	uM	0.002
	18327479	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COc1cc2ncc(-c3cc(N)nc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4166239	=	IC50	nM	6.0	CHEMBL5014	Homo sapiens	IC50	uM	0.006
	18327480	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CCOc1cc2ncc(-c3cc(N)nc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4161723	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	uM	0.005
	18327481	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CC(C)(C)S(=O)(=O)c1cn2c(-c3cc(N)nc(Cl)c3)cnc2cc1OC1CC1		CHEMBL4169652	=	IC50	nM	58.0	CHEMBL5014	Homo sapiens	IC50	uM	0.058
	18327482	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CC(C)Oc1cc2ncc(-c3cc(N)nc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4170048	=	IC50	nM	7.0	CHEMBL5014	Homo sapiens	IC50	uM	0.007
	18327483	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CC(C)(C)S(=O)(=O)c1cn2c(-c3cc(N)nc(Cl)c3)cnc2cc1OCC(F)(F)F		CHEMBL4159424	=	IC50	nM	7.0	CHEMBL5014	Homo sapiens	IC50	uM	0.007
	18327484	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	COCCOc1cc2ncc(-c3cc(N)nc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4173493	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	uM	0.005
	18327485	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CN1CCN(CCOc2cc3ncc(-c4cc(N)nc(Cl)c4)n3cc2S(=O)(=O)C(C)(C)C)CC1		CHEMBL4162788	=	IC50	nM	8.0	CHEMBL5014	Homo sapiens	IC50	uM	0.008
	18327486	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4171924	=	IC50	nM	3.0	CHEMBL5014	Homo sapiens	IC50	uM	0.003
	18327487	CHEMBL4135584	Inhibition of full length RIPK2 (unknown origin) pretreated for 30 mins followed by ATP addition measured after 2 hrs by ADP-d2 tracer based fluorescence assay	B	CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)C		CHEMBL4161327	=	IC50	nM	3.0	CHEMBL5014	Homo sapiens	IC50	uM	0.003
	18327551	CHEMBL4135591	Inhibition of RIPK2 in human PBMCs assessed as reduction in MDP-stimulated IL8 secretion measured after 18 hrs	B	COc1cc2ncc(-c3ccc4[nH]ncc4c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4167668	=	IC50	nM	130.0	CHEMBL5014	Homo sapiens	IC50	uM	0.13
	18327552	CHEMBL4135591	Inhibition of RIPK2 in human PBMCs assessed as reduction in MDP-stimulated IL8 secretion measured after 18 hrs	B	COc1cc2ncc(-c3cccc(NC(C)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4171039	=	IC50	nM	32.0	CHEMBL5014	Homo sapiens	IC50	uM	0.032
	18327553	CHEMBL4135591	Inhibition of RIPK2 in human PBMCs assessed as reduction in MDP-stimulated IL8 secretion measured after 18 hrs	B	COc1cc2ncc(-c3ccnc(N)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4173646	=	IC50	nM	29.0	CHEMBL5014	Homo sapiens	IC50	uM	0.029
	18327554	CHEMBL4135591	Inhibition of RIPK2 in human PBMCs assessed as reduction in MDP-stimulated IL8 secretion measured after 18 hrs	B	COc1cc2ncc(-c3ccnc(NC(C)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4165728	=	IC50	nM	40.0	CHEMBL5014	Homo sapiens	IC50	uM	0.04
	18327555	CHEMBL4135591	Inhibition of RIPK2 in human PBMCs assessed as reduction in MDP-stimulated IL8 secretion measured after 18 hrs	B	COc1cc2ncc(-c3cc(Cl)cc(NC(C)=O)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4176853	=	IC50	nM	9.0	CHEMBL5014	Homo sapiens	IC50	uM	0.009
	18327556	CHEMBL4135591	Inhibition of RIPK2 in human PBMCs assessed as reduction in MDP-stimulated IL8 secretion measured after 18 hrs	B	COc1cc2ncc(-c3cc(N)nc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4166239	=	IC50	nM	9.0	CHEMBL5014	Homo sapiens	IC50	uM	0.009
	18327591	CHEMBL4135616	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha secretion pretreated for 30 mins followed by MDP stimulation measured after 20 hrs	B	CCOc1cc2ncc(-c3cc(N)nc(F)c3)n2cc1S(=O)(=O)C(C)C		CHEMBL4161327	=	IC50	nM	30.0	CHEMBL5014	Homo sapiens	IC50	uM	0.03
	18440428	CHEMBL4157252	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	18443322	CHEMBL4157917	Inhibition of human RIPK2 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	85.0	CHEMBL5014	Homo sapiens	Activity	%	85.0
	18449939	CHEMBL4178173	Inhibition of human RIPK2 (2 to 311 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	30.0	CHEMBL5014	Homo sapiens	Activity	%	30.0
	18449946	CHEMBL4178180	Inhibition of human RIPK2 (2 to 311 residues) at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Inhibition	%	70.0	CHEMBL5014	Homo sapiens	INH	%	70.0
	18462194	CHEMBL4180881	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	94.0	CHEMBL5014	Homo sapiens	Activity	%	94.0
	18483943	CHEMBL4185506	Inhibition of human RIPK2 expressed in Sf9 cells after 1 hr by ADP-Glo assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	6.7	CHEMBL5014	Homo sapiens	IC50	nM	6.7
	18484384	CHEMBL4186031	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	89.0	CHEMBL5014	Homo sapiens	Activity	%	89.0
	18484868	CHEMBL4186031	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	98.0	CHEMBL5014	Homo sapiens	Activity	%	98.0
	18496262	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)cc3)c(F)c2)ccn1		CHEMBL4209950	=	Inhibition	%	17.0	CHEMBL5014	Homo sapiens	INH	%	17.0
Not Determined	18496263	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(CC(=O)O)cc3)c(F)c2)ccn1		CHEMBL4203730		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496264	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(SCC(=O)O)c3)c(F)c2)ccn1		CHEMBL4215408		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	18496265	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)(C)C(=O)O)c3)c(F)c2)ccn1		CHEMBL4208092	=	Inhibition	%	67.0	CHEMBL5014	Homo sapiens	INH	%	67.0
	18496266	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CC(=O)OC)c3)c(F)c2)ccn1		CHEMBL4203221	=	Inhibition	%	76.0	CHEMBL5014	Homo sapiens	INH	%	76.0
Not Active	18496267	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CC(=O)O)c3)c(F)c2)ccn1		CHEMBL4214124		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496268	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)(C)N)c3)c(F)c2)ccn1		CHEMBL4212847		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496269	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CCN)c3)c(F)c2)ccn1		CHEMBL4211751		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496270	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(N4CC(=O)NS4(=O)=O)c(C)c3)c(F)c2)ccn1		CHEMBL4211955		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496271	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(OCCS(C)(=O)=O)c(C)c3)c(F)c2)ccn1		CHEMBL4210831		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496272	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CC#N)c3)c(F)c2)ccn1		CHEMBL4218905		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496273	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(=O)O)c3)c(F)c2)ccn1		CHEMBL4212885		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Determined	18496274	CHEMBL4188389	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(C(=O)O)cc3)c(F)c2)ccn1		CHEMBL4209160		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	18496275	CHEMBL4188388	Inhibition of wild type recombinant human His6-tagged RIPK2 at 1 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)OC)c(F)c3)c(F)c2)ccn1		CHEMBL4209033	=	Inhibition	%	94.0	CHEMBL5014	Homo sapiens	INH	%	94.0
	18496276	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)c(F)c3)c(F)c2)ccn1		CHEMBL4206212	=	Inhibition	%	70.0	CHEMBL5014	Homo sapiens	INH	%	70.0
	18496277	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)cc3)c(F)c2)ccn1		CHEMBL4209950	=	Inhibition	%	27.0	CHEMBL5014	Homo sapiens	INH	%	27.0
	18496278	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(CC(=O)O)cc3)c(F)c2)ccn1		CHEMBL4203730	=	Inhibition	%	18.0	CHEMBL5014	Homo sapiens	INH	%	18.0
	18496279	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(SCC(=O)O)c3)c(F)c2)ccn1		CHEMBL4215408	=	Inhibition	%	25.0	CHEMBL5014	Homo sapiens	INH	%	25.0
	18496280	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)(C)C(=O)O)c3)c(F)c2)ccn1		CHEMBL4208092	=	Inhibition	%	47.0	CHEMBL5014	Homo sapiens	INH	%	47.0
	18496281	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CC(=O)OC)c3)c(F)c2)ccn1		CHEMBL4203221	=	Inhibition	%	69.0	CHEMBL5014	Homo sapiens	INH	%	69.0
Not Active	18496282	CHEMBL4188387	Inhibition of wild type recombinant human His6-tagged RIPK2 at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CC(=O)O)c3)c(F)c2)ccn1		CHEMBL4214124		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	18496283	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(C)(C)N)c3)c(F)c2)ccn1		CHEMBL4212847	=	Inhibition	%	32.0	CHEMBL5014	Homo sapiens	INH	%	32.0
	18496284	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CCN)c3)c(F)c2)ccn1		CHEMBL4211751	=	Inhibition	%	12.0	CHEMBL5014	Homo sapiens	INH	%	12.0
	18496285	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(N4CC(=O)NS4(=O)=O)c(C)c3)c(F)c2)ccn1		CHEMBL4211955	=	Inhibition	%	1.0	CHEMBL5014	Homo sapiens	INH	%	1.0
	18496286	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(OCCS(C)(=O)=O)c(C)c3)c(F)c2)ccn1		CHEMBL4210831	=	Inhibition	%	35.0	CHEMBL5014	Homo sapiens	INH	%	35.0
	18496287	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(CC#N)c3)c(F)c2)ccn1		CHEMBL4218905	=	Inhibition	%	43.0	CHEMBL5014	Homo sapiens	INH	%	43.0
Not Active	18496288	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(=O)O)c3)c(F)c2)ccn1		CHEMBL4212885		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	18496289	CHEMBL4188386	Inhibition of wild type recombinant human His6-tagged RIPK2 at 0.5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(C(=O)O)cc3)c(F)c2)ccn1		CHEMBL4209160		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	18496290	CHEMBL4188390	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 5 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)c(F)c3)c(F)c2)ccn1		CHEMBL4206212	=	Inhibition	%	64.0	CHEMBL5014	Homo sapiens	INH	%	64.0
	18496291	CHEMBL4188391	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant at 1 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)OC)c(F)c3)c(F)c2)ccn1		CHEMBL4209033	=	Inhibition	%	92.0	CHEMBL5014	Homo sapiens	INH	%	92.0
	18496292	CHEMBL4188392	Inhibition of wild type recombinant human His6-tagged RIPK2 using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)c(F)c3)c(F)c2)ccn1		CHEMBL4206212	=	IC50	nM	2260.0	CHEMBL5014	Homo sapiens	IC50	uM	2.26
	18496293	CHEMBL4188392	Inhibition of wild type recombinant human His6-tagged RIPK2 using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	O=C(O)CSc1ccc(NC(=O)Nc2ccccc2F)cc1F		CHEMBL4218871	=	IC50	nM	13200.0	CHEMBL5014	Homo sapiens	IC50	uM	13.2
	18496294	CHEMBL4188393	Inhibition of recombinant human His6-tagged RIPK2 R171C mutant using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(SCC(=O)O)c(F)c3)c(F)c2)ccn1		CHEMBL4206212	=	IC50	nM	4870.0	CHEMBL5014	Homo sapiens	IC50	uM	4.87
	18496297	CHEMBL4188396	Inhibition of wild type recombinant human His6-tagged RIPK2 at 10 uM using RS repeat peptide substrate incubated for 2 hrs by ADP-Glo assay	B	Nc1ccc(SCC(=O)O)c(F)c1		CHEMBL4212464	=	Inhibition	%	10.0	CHEMBL5014	Homo sapiens	INH	%	10.0
	18507624	CHEMBL4191168	Inhibition of recombinant human RIPK2 (1 to 299 residues) at 1 uM using myelin basic protein as substrate after 120 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	70.0	CHEMBL5014	Homo sapiens	INH	%	70.0
	18653389	CHEMBL4230211	Inhibition of RIPK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	98.0	CHEMBL5014	Homo sapiens	INH	%	98.0
	18653390	CHEMBL4230211	Inhibition of RIPK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	82.0	CHEMBL5014	Homo sapiens	INH	%	82.0
	18655304	CHEMBL4230931	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	93.0	CHEMBL5014	Homo sapiens	Activity	%	93.0
	18737870	CHEMBL4261375	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system by Kinomescan method	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	>	Kd	nM	10000.0	CHEMBL5014	Homo sapiens	Kd	nM	10000.0
	18751225	CHEMBL4263934	Inhibition of RIPK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	90.0	CHEMBL5014	Homo sapiens	INH	%	90.0
	18752183	CHEMBL4264520	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	96.0	CHEMBL5014	Homo sapiens	Activity	%	96.0
	18764656	CHEMBL4267121	Inhibition of human RIPK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL5014	Homo sapiens	INH	%	70.0
	18764657	CHEMBL4267121	Inhibition of human RIPK2 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	=	Inhibition	%	70.0	CHEMBL5014	Homo sapiens	INH	%	70.0
	18764658	CHEMBL4267121	Inhibition of human RIPK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL5014	Homo sapiens	INH	%	70.0
	18778856	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	nM	5.0
	18778857	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ncc(F)cc34)c2c1		CHEMBL4278565	=	IC50	nM	79.0	CHEMBL5014	Homo sapiens	IC50	nM	79.0
	18778858	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4c3CCCC4)c2c1		CHEMBL4286477	=	IC50	nM	5012.0	CHEMBL5014	Homo sapiens	IC50	nM	5012.0
	18778859	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3cc[nH]n3)c2c1		CHEMBL4293701	=	IC50	nM	794.0	CHEMBL5014	Homo sapiens	IC50	nM	794.0
	18778860	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	Cc1cc(Nc2ccnc3ccc(S(=O)(=O)C(C)(C)C)cc23)n[nH]1		CHEMBL4283104	=	IC50	nM	126.0	CHEMBL5014	Homo sapiens	IC50	nM	126.0
	18778861	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	Cc1[nH]nc(Nc2ccnc3ccc(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4285462	=	IC50	nM	6.3	CHEMBL5014	Homo sapiens	IC50	nM	6.3
	18778862	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	=	IC50	nM	1.3	CHEMBL5014	Homo sapiens	IC50	nM	1.3
	18778863	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	CCOc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4282034	=	IC50	nM	1.6	CHEMBL5014	Homo sapiens	IC50	nM	1.6
	18778864	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	Cc1[nH]nc(Nc2ccnc3cc(OCCO)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4289904	=	IC50	nM	2.5	CHEMBL5014	Homo sapiens	IC50	nM	2.5
	18778865	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	COCCOc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4292228	=	IC50	nM	2.5	CHEMBL5014	Homo sapiens	IC50	nM	2.5
	18778866	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	Cc1[nH]nc(Nc2ccnc3cc(OC(F)(F)F)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4281602	=	IC50	nM	6.3	CHEMBL5014	Homo sapiens	IC50	nM	6.3
	18778867	CHEMBL4269598	Inhibition of full length His/flag-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescently labeled substrate incubated for 10 mins followed by substrate addition measured after 10 mins by fluorescence polarization assay	B	CCc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4285837	=	IC50	nM	2.5	CHEMBL5014	Homo sapiens	IC50	nM	2.5
	18778868	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	IC50	nM	237.0	CHEMBL5014	Homo sapiens	IC50	nM	237.0
	18778869	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ncc(F)cc34)c2c1		CHEMBL4278565	=	IC50	nM	1380.0	CHEMBL5014	Homo sapiens	IC50	nM	1380.0
	18778870	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4c3CCCC4)c2c1		CHEMBL4286477	=	IC50	nM	4719.0	CHEMBL5014	Homo sapiens	IC50	nM	4719.0
	18778871	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3cc[nH]n3)c2c1		CHEMBL4293701	=	IC50	nM	3226.0	CHEMBL5014	Homo sapiens	IC50	nM	3226.0
	18778872	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	Cc1cc(Nc2ccnc3ccc(S(=O)(=O)C(C)(C)C)cc23)n[nH]1		CHEMBL4283104	=	IC50	nM	742.0	CHEMBL5014	Homo sapiens	IC50	nM	742.0
	18778873	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	Cc1[nH]nc(Nc2ccnc3ccc(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4285462	=	IC50	nM	100.0	CHEMBL5014	Homo sapiens	IC50	nM	100.0
	18778874	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	=	IC50	nM	11.0	CHEMBL5014	Homo sapiens	IC50	nM	11.0
	18778875	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	CCOc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4282034	=	IC50	nM	41.0	CHEMBL5014	Homo sapiens	IC50	nM	41.0
	18778876	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	Cc1[nH]nc(Nc2ccnc3cc(OCCO)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4289904	=	IC50	nM	15.0	CHEMBL5014	Homo sapiens	IC50	nM	15.0
	18778877	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	COCCOc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4292228	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	nM	5.0
	18778878	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	Cc1[nH]nc(Nc2ccnc3cc(OC(F)(F)F)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4281602	=	IC50	nM	446.0	CHEMBL5014	Homo sapiens	IC50	nM	446.0
	18778879	CHEMBL4269599	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-stimulated TNFalpha levels incubated for 30 mins followed by MDP addition measured after 5 hrs	B	CCc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4285837	=	IC50	nM	154.0	CHEMBL5014	Homo sapiens	IC50	nM	154.0
	18782820	CHEMBL4270686	Inhibition of RIPK2 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	11.0	CHEMBL5014	Homo sapiens	Activity	%	11.0
	18858183	CHEMBL4308029	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	18881254	CHEMBL4312064	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	10.0	CHEMBL5014	Homo sapiens	Ki	nM	10.0
	18892962	CHEMBL4314928	Inhibition of human RIPK2 (1 to 299 residues) using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL5014	Homo sapiens	Activity	%	105.5
	18902076	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	COc1cccc(-c2nn(C(C)(C)C)c(N)c2C(N)=O)c1		CHEMBL4440460	=	IC50	nM	1500.0	CHEMBL5014	Homo sapiens	IC50	uM	1.5
	18902077	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	COc1cc(-c2nn(C(C)(C)C)c(N)c2C(N)=O)ccc1Cl		CHEMBL4517939	=	IC50	nM	80.0	CHEMBL5014	Homo sapiens	IC50	uM	0.08
	18902078	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	Cc1cccc(-c2nn(C(C)(C)C)c(N)c2C(N)=O)c1		CHEMBL4447649	=	IC50	nM	5000.0	CHEMBL5014	Homo sapiens	IC50	uM	5.0
	18902079	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc(Cl)c(Cl)c2)c(C(N)=O)c1N		CHEMBL4562524	=	IC50	nM	120.0	CHEMBL5014	Homo sapiens	IC50	uM	0.12
	18902080	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3[nH]ncc3c2)c(C(N)=O)c1N		CHEMBL4445319	=	IC50	nM	1200.0	CHEMBL5014	Homo sapiens	IC50	uM	1.2
	18902081	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c(C(N)=O)c1N		CHEMBL3108912	=	IC50	nM	60.0	CHEMBL5014	Homo sapiens	IC50	uM	0.06
	18902082	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	COc1cccc(-n2nc(C(C)(C)C)c(C(N)=O)c2N)c1		CHEMBL4467414	=	IC50	nM	32000.0	CHEMBL5014	Homo sapiens	IC50	uM	32.0
	18902083	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	COc1cc(-n2nc(C(C)(C)C)c(C(N)=O)c2N)ccc1Cl		CHEMBL4585896	=	IC50	nM	20000.0	CHEMBL5014	Homo sapiens	IC50	uM	20.0
	18902084	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	Cc1cccc(-n2nc(C(C)(C)C)c(C(N)=O)c2N)c1		CHEMBL4461529	=	IC50	nM	25000.0	CHEMBL5014	Homo sapiens	IC50	uM	25.0
	18902085	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)c1nn(-c2ccc(Cl)c(Cl)c2)c(N)c1C(N)=O		CHEMBL4550595	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18902086	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)c1nn(-c2ccc3[nH]ncc3c2)c(N)c1C(N)=O		CHEMBL4566800	=	IC50	nM	25000.0	CHEMBL5014	Homo sapiens	IC50	uM	25.0
	18902087	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)c1nn(-c2ccc3ccccc3c2)c(N)c1C(N)=O		CHEMBL4550438	=	IC50	nM	50000.0	CHEMBL5014	Homo sapiens	IC50	uM	50.0
	18902088	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3c(c2)OCO3)c(C(N)=O)c1N		CHEMBL4568258	=	IC50	nM	790.0	CHEMBL5014	Homo sapiens	IC50	uM	0.79
	18902089	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3nonc3c2)c(C(N)=O)c1N		CHEMBL4461710	=	IC50	nM	790.0	CHEMBL5014	Homo sapiens	IC50	uM	0.79
	18902090	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3[nH]cnc3c2)c(C(N)=O)c1N		CHEMBL4563063	=	IC50	nM	3200.0	CHEMBL5014	Homo sapiens	IC50	uM	3.2
	18902091	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3cc[nH]c3c2)c(C(N)=O)c1N		CHEMBL4482915	=	IC50	nM	120.0	CHEMBL5014	Homo sapiens	IC50	uM	0.12
	18902092	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CC(C)(C)n1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N		CHEMBL4437124	=	IC50	nM	40.0	CHEMBL5014	Homo sapiens	IC50	uM	0.04
	18902093	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N		CHEMBL4561931	=	IC50	nM	50.0	CHEMBL5014	Homo sapiens	IC50	uM	0.05
	18902094	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1NC		CHEMBL4475515	=	IC50	nM	60.0	CHEMBL5014	Homo sapiens	IC50	uM	0.06
	18902095	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCC2		CHEMBL4558980	=	IC50	nM	250.0	CHEMBL5014	Homo sapiens	IC50	uM	0.25
	18902096	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCC2		CHEMBL4535795	=	IC50	nM	60.0	CHEMBL5014	Homo sapiens	IC50	uM	0.06
	18902097	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCCC2		CHEMBL4475766	=	IC50	nM	25.0	CHEMBL5014	Homo sapiens	IC50	uM	0.025
	18902098	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@@H]1CC[C@@H](C1)C2		CHEMBL4551566	=	IC50	nM	50.0	CHEMBL5014	Homo sapiens	IC50	uM	0.05
	18902099	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@@H]1C[C@@H](C[C@H]1O)C2		CHEMBL4453606	=	IC50	nM	60.0	CHEMBL5014	Homo sapiens	IC50	uM	0.06
	18902100	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](C[C@@H]1O)C2		CHEMBL4527824	=	IC50	nM	30.0	CHEMBL5014	Homo sapiens	IC50	uM	0.03
	18902101	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](O)[C@H](C1)C2		CHEMBL4583311	=	IC50	nM	160.0	CHEMBL5014	Homo sapiens	IC50	uM	0.16
	18902102	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@@H](C2)[C@H](O)C1		CHEMBL4562422	=	IC50	nM	80.0	CHEMBL5014	Homo sapiens	IC50	uM	0.08
	18902103	CHEMBL4316520	Inhibition of full length FLAG/His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system after 10 mins by fluorescent polarization assay	B	NC(=O)c1cnn(-c2ccccc2)c1N		CHEMBL4544218	=	IC50	nM	80000.0	CHEMBL5014	Homo sapiens	IC50	uM	80.0
	18902104	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	CC(C)(C)n1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N		CHEMBL4437124	=	IC50	nM	540.0	CHEMBL5014	Homo sapiens	IC50	uM	0.54
	18902105	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1N		CHEMBL4561931	=	IC50	nM	640.0	CHEMBL5014	Homo sapiens	IC50	uM	0.64
	18902106	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	CCn1nc(-c2ccc3scnc3c2)c(C(N)=O)c1NC		CHEMBL4475515	=	IC50	nM	120.0	CHEMBL5014	Homo sapiens	IC50	uM	0.12
	18902107	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCC2		CHEMBL4558980	=	IC50	nM	1150.0	CHEMBL5014	Homo sapiens	IC50	uM	1.15
	18902108	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCC2		CHEMBL4535795	=	IC50	nM	700.0	CHEMBL5014	Homo sapiens	IC50	uM	0.7
	18902109	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1NCCCCC2		CHEMBL4475766	=	IC50	nM	370.0	CHEMBL5014	Homo sapiens	IC50	uM	0.37
	18902110	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@@H]1CC[C@@H](C1)C2		CHEMBL4551566	=	IC50	nM	290.0	CHEMBL5014	Homo sapiens	IC50	uM	0.29
	18902111	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@@H]1C[C@@H](C[C@H]1O)C2		CHEMBL4453606	=	IC50	nM	280.0	CHEMBL5014	Homo sapiens	IC50	uM	0.28
	18902112	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](C[C@@H]1O)C2		CHEMBL4527824	=	IC50	nM	50.0	CHEMBL5014	Homo sapiens	IC50	uM	0.05
	18902113	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@H](O)[C@H](C1)C2		CHEMBL4583311	=	IC50	nM	220.0	CHEMBL5014	Homo sapiens	IC50	uM	0.22
	18902114	CHEMBL4316521	Inhibition of RIPK2 in MDP-stimulated human whole blood assessed as TNF-alpha level preincubated for 30 mins followed by MDP stimulation and measured after 6 hrs by immunoassay	B	NC(=O)c1c(-c2ccc3scnc3c2)nn2c1N[C@H]1C[C@@H](C2)[C@H](O)C1		CHEMBL4562422	=	IC50	nM	190.0	CHEMBL5014	Homo sapiens	IC50	uM	0.19
	18938267	CHEMBL4327860	Inhibition of human RIPK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	95.39	CHEMBL5014	Homo sapiens	Activity	%	95.39
	18938268	CHEMBL4327860	Inhibition of human RIPK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	86.59	CHEMBL5014	Homo sapiens	Activity	%	86.59
	18938705	CHEMBL4328224	Inhibition of human RIPK2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5014	Homo sapiens	Activity	%	65.0
	18939090	CHEMBL4328588	Inhibition of human RIPK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	317.0	CHEMBL5014	Homo sapiens	IC50	10'-7M	3.17
	18958577	CHEMBL4333614	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	82.0	CHEMBL5014	Homo sapiens	Activity	%	82.0
	18964654	CHEMBL4335268	Inhibition of recombinant human RIPK2 (1 to 299 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	66.0	CHEMBL5014	Homo sapiens	Activity	%	66.0
	18964655	CHEMBL4335268	Inhibition of recombinant human RIPK2 (1 to 299 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	62.0	CHEMBL5014	Homo sapiens	Activity	%	62.0
	18972081	CHEMBL4337091	Inhibition of recombinant human RIPK2 (1 to 299 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 120 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	23.0	CHEMBL5014	Homo sapiens	Activity	%	23.0
	18976034	CHEMBL4338197	Inhibition of RIPK2 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12		CHEMBL4555884	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18976035	CHEMBL4338197	Inhibition of RIPK2 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12		CHEMBL4475097	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18976036	CHEMBL4338197	Inhibition of RIPK2 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	IC50	nM	1100.0	CHEMBL5014	Homo sapiens	IC50	uM	1.1
	18976037	CHEMBL4338197	Inhibition of RIPK2 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4446434	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18976038	CHEMBL4338197	Inhibition of RIPK2 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12		CHEMBL4476426	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18976039	CHEMBL4338197	Inhibition of RIPK2 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4548361	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	18976054	CHEMBL4338202	Inhibition of RIPK2 (unknown origin) assessed as residual enzyme activity at 50 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	10.0	CHEMBL5014	Homo sapiens	Activity	%	10.0
	18976062	CHEMBL4338210	Inhibition of RIPK2 (unknown origin) assessed as residual enzyme activity at 1 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	41.0	CHEMBL5014	Homo sapiens	Activity	%	41.0
	18976087	CHEMBL4338234	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	57.0	CHEMBL5014	Homo sapiens	Activity	%	57.0
	19008083	CHEMBL4344881	Displacement of fluorescein labeled probe from full length human GST-tagged RIPK2 expressed in Sf9 cells incubated for 60 mins by HTRF assay	A	Nc1ccc(C#Cc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2N)nc1		CHEMBL4470115	=	IC50	nM	2400.0	CHEMBL5014	Homo sapiens	IC50	nM	2400.0
	19008084	CHEMBL4344881	Displacement of fluorescein labeled probe from full length human GST-tagged RIPK2 expressed in Sf9 cells incubated for 60 mins by HTRF assay	A	Cc1ccc(COC(=O)Nc2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL4434926	=	IC50	nM	50.0	CHEMBL5014	Homo sapiens	IC50	nM	50.0
	19008098	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	CC#Cc1c(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ccnc1N		CHEMBL4552106	=	IC50	nM	3000.0	CHEMBL5014	Homo sapiens	IC50	uM	3.0
	19008099	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL509101	>	IC50	nM	15000.0	CHEMBL5014	Homo sapiens	IC50	uM	15.0
	19008100	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4455682	=	IC50	nM	1800.0	CHEMBL5014	Homo sapiens	IC50	uM	1.8
	19008101	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccncc2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4572309	>	IC50	nM	15000.0	CHEMBL5014	Homo sapiens	IC50	uM	15.0
	19008102	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccncc2)c(F)c1)c1cccc(-c2ccc(F)cc2)c1		CHEMBL4468222	>	IC50	nM	15000.0	CHEMBL5014	Homo sapiens	IC50	uM	15.0
	19008103	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc(C)c1Oc1ccncc1		CHEMBL4542026	=	IC50	nM	13000.0	CHEMBL5014	Homo sapiens	IC50	uM	13.0
	19008104	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccncc2)c1C		CHEMBL4434881	>	IC50	nM	15000.0	CHEMBL5014	Homo sapiens	IC50	uM	15.0
	19008105	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	O=C(Nc1ccc(Oc2ccncc2)c2ccccc12)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4438939	>	IC50	nM	15000.0	CHEMBL5014	Homo sapiens	IC50	uM	15.0
	19008106	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc1Oc1ccnc(NC(=O)C2CC2)c1		CHEMBL4476485	=	IC50	nM	680.0	CHEMBL5014	Homo sapiens	IC50	uM	0.68
	19008107	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1cc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc(C)c1Oc1ccnc(NC(=O)C2CC2)c1		CHEMBL4476076	=	IC50	nM	3100.0	CHEMBL5014	Homo sapiens	IC50	uM	3.1
	19008108	CHEMBL4344884	Displacement of fluorescein labeled ATP probe from His/GST-tagged RIPK2 (unknown origin) incubated for 60 mins by HTRF assay	A	Cc1c(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)ccc(Oc2ccnc(NC(=O)C3CC3)c2)c1C		CHEMBL4551490	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	19008133	CHEMBL4344889	Time dependent inhibition of full length His/GST-tagged RIPK2 (unknown origin) measured every 5 mins for 60 mins in presence of fluorescein labeled probe by HTRF assay relative to control	A	Nc1ccc(C#Cc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2N)nc1		CHEMBL4470115	=	FC		6.0	CHEMBL5014	Homo sapiens	FC		6.0
	19008135	CHEMBL4344889	Time dependent inhibition of full length His/GST-tagged RIPK2 (unknown origin) measured every 5 mins for 60 mins in presence of fluorescein labeled probe by HTRF assay relative to control	A	Cc1ccc(COC(=O)Nc2cc(-c3cc4c([nH]3)CCNC4=O)ccn2)cc1		CHEMBL4434926	=	FC		2.0	CHEMBL5014	Homo sapiens	FC		2.0
	19009304	CHEMBL4345215	Inhibition of wild type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	>	Inhibition	%	80.0	CHEMBL5014	Homo sapiens	INH	%	80.0
Not Active	19040139	CHEMBL4352040	Inhibition of human RIPK2 (1 to 299 residues) using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Active	19041266	CHEMBL4352527	Inhibition of human RIPK2 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	19052743	CHEMBL4355552	Inhibition of human RIPK2 at 1 uM relative to control	B	COc1n[nH]c2ncc(-c3cn(-c4c(F)ccc(NS(=O)(=O)c5cccc(-c6ccccc6)c5)c4F)nn3)cc12		CHEMBL4450810	>	Inhibition	%	90.0	CHEMBL5014	Homo sapiens	INH	%	90.0
	19052780	CHEMBL4355588	Binding affinity to human RIPK2	B	COc1n[nH]c2ncc(-c3cn(-c4c(F)ccc(NS(=O)(=O)c5cccc(-c6ccccc6)c5)c4F)nn3)cc12		CHEMBL4450810	=	Kd	nM	57.0	CHEMBL5014	Homo sapiens	Kd	nM	57.0
	19059808	CHEMBL4358109	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	19090372	CHEMBL4365946	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	19092099	CHEMBL4366573	Inhibition of human RIPK2 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	14.18	CHEMBL5014	Homo sapiens	INH	%	14.18
	19095233	CHEMBL4367435	Inhibition of fluorescent-labelled ligand binding to human RIP2K preincubated for 10 mins followed by fluorescent-labelled ligand addition and measured after 10 mins by fluorescence polarization assay	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	nM	5.0
	19095234	CHEMBL4367435	Inhibition of fluorescent-labelled ligand binding to human RIP2K preincubated for 10 mins followed by fluorescent-labelled ligand addition and measured after 10 mins by fluorescence polarization assay	B	COc1cc2ncnc(Nc3ccc4scnc4c3)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4473105	=	IC50	nM	4.0	CHEMBL5014	Homo sapiens	IC50	nM	4.0
	19095239	CHEMBL4367440	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-induced TNFalpha production preincubated for 30 mins followed by MDP-stimulation and measured after 6 hrs by immunoassay	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	IC50	nM	26.0	CHEMBL5014	Homo sapiens	IC50	nM	26.0
	19095240	CHEMBL4367440	Inhibition of RIPK2 in human whole blood assessed as reduction in MDP-induced TNFalpha production preincubated for 30 mins followed by MDP-stimulation and measured after 6 hrs by immunoassay	B	COc1cc2ncnc(Nc3ccc4scnc4c3)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4473105	=	IC50	nM	374.0	CHEMBL5014	Homo sapiens	IC50	nM	374.0
	19114511	CHEMBL4371409	Binding affinity to RIPK2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	43.0	CHEMBL5014	Homo sapiens	Kd(free)	uM	0.043
	19114681	CHEMBL4371409	Binding affinity to RIPK2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	17.0	CHEMBL5014	Homo sapiens	Kd(free)	uM	0.017
Active	19114760	CHEMBL4371395	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL5014	Homo sapiens	Activity		
Active	19114785	CHEMBL4371395	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL5014	Homo sapiens	Activity		
	19144828	CHEMBL4377844	Inhibition of human RIPK2 (1 to 299 residues) at 1 uM using myelin basic protein as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	24.0	CHEMBL5014	Homo sapiens	INH	%	24.0
	19146699	CHEMBL4378730	Inhibition of recombinant human His-tagged RIPK2 (8 to 317 residues) incubated for 1 hr by ADP-Glo assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.0	CHEMBL5014	Homo sapiens	IC50	nM	1.0
	19146700	CHEMBL4378730	Inhibition of recombinant human His-tagged RIPK2 (8 to 317 residues) incubated for 1 hr by ADP-Glo assay	B	Cc1ccc(CCCCN2C(=O)N[C@H](Cc3c[nH]c4c(Cl)cccc34)C2=O)cc1C#Cc1cnc2cccnn12		CHEMBL4464634	=	IC50	nM	1193.0	CHEMBL5014	Homo sapiens	IC50	nM	1193.0
	19146735	CHEMBL4378749	Inhibition of human RIPK2 using MBP as substrate by [gamma33-ATP] based radiometric assay	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	IC50	nM	77.0	CHEMBL5014	Homo sapiens	IC50	nM	77.0
	19146965	CHEMBL4378827	Inhibition of human RIPK2 (1 to 299 residues) at 10 uM using MBP as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	6.0	CHEMBL5014	Homo sapiens	INH	%	6.0
	19148023	CHEMBL4379419	Inhibition of recombinant human RIPK2 (1 to 299 residues) using MBP as substrate incubated for 120 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5014	Homo sapiens	IC50	uM	10.0
	19159636	CHEMBL4382740	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	81.0	CHEMBL5014	Homo sapiens	Activity	%	81.0
	19181131	CHEMBL4387342	Inhibition of tracer 178 binding to recombinant human His-tagged RIPK2 catalytic domain (1 to 299 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	1.1	CHEMBL5014	Homo sapiens	INH	%	1.1
	19181356	CHEMBL4387342	Inhibition of tracer 178 binding to recombinant human His-tagged RIPK2 catalytic domain (1 to 299 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	2.0	CHEMBL5014	Homo sapiens	INH	%	2.0
	19191371	CHEMBL4389459	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5014	Homo sapiens	INH	%	100.0
	19192122	CHEMBL4389936	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5014	Homo sapiens	INH	%	100.0
	19200378	CHEMBL4391562	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	66.0	CHEMBL5014	Homo sapiens	Activity	%	66.0
Active	19218914	CHEMBL4394529	Binding affinity to RIPK2 in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis	B	C#Cc1cccc(Nc2ccnc3cc(OC)c(OC)cc23)c1		CHEMBL1092250		Activity			CHEMBL5014	Homo sapiens	Activity		
	19243681	CHEMBL4400271	Inhibition of human RIPK2 at 1 uM relative to control	B	CN(C)Cc1ccn2c(-c3ccnc(N)n3)c(-c3ccc(F)cc3)nc2c1		CHEMBL425949	=	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	19243682	CHEMBL4400271	Inhibition of human RIPK2 at 1 uM relative to control	B	CN(C)Cc1ccn2c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)c(C3CC3)nc2c1		CHEMBL4437958	=	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	19243683	CHEMBL4400271	Inhibition of human RIPK2 at 1 uM relative to control	B	CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cc(NCCN(C)C)ccn23)n1		CHEMBL4474940	=	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	19266593	CHEMBL4405543	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	19276112	CHEMBL4408115	Inhibition of recombinant human RIPK2 (1 to 299 residues) at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	46.0	CHEMBL5014	Homo sapiens	INH	%	46.0
	19303860	CHEMBL4414293	Inhibition of RIPK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	86.0	CHEMBL5014	Homo sapiens	Activity	%	86.0
	19485722	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1ccc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2c1		CHEMBL4592501	=	Kd	nM	170.0	CHEMBL5014	Homo sapiens	Kd	nM	170.0
	19485727	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	42.0	CHEMBL5014	Homo sapiens	Kd	nM	42.0
	19485731	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccccc23)cc(OC)c1OC		CHEMBL4586588	=	Kd	nM	2900.0	CHEMBL5014	Homo sapiens	Kd	nM	2900.0
	19485737	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1ccc2c(Nc3cc(OC)c(OC)c(OC)c3)ccnc2c1		CHEMBL4586530	=	Kd	nM	200.0	CHEMBL5014	Homo sapiens	Kd	nM	200.0
	19485740	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	180.0	CHEMBL5014	Homo sapiens	Kd	nM	180.0
	19485751	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(I)cc23)cc(OC)c1OC		CHEMBL4517424	=	Kd	nM	69.0	CHEMBL5014	Homo sapiens	Kd	nM	69.0
	19485752	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Kd	nM	110.0	CHEMBL5014	Homo sapiens	Kd	nM	110.0
	19485753	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC		CHEMBL4575895	=	Kd	nM	96.0	CHEMBL5014	Homo sapiens	Kd	nM	96.0
	19485754	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C(C)(C)C)cc23)cc(OC)c1OC		CHEMBL530635	=	Kd	nM	670.0	CHEMBL5014	Homo sapiens	Kd	nM	670.0
	19485755	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(Cl)cc23)cc(OC)c1OC		CHEMBL4556662	=	Kd	nM	85.0	CHEMBL5014	Homo sapiens	Kd	nM	85.0
	19485757	CHEMBL4481499	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C#N)cc23)cc(OC)c1OC		CHEMBL4585158	=	Kd	nM	88.0	CHEMBL5014	Homo sapiens	Kd	nM	88.0
	19485792	CHEMBL4481511	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	IC50	nM	360.0	CHEMBL5014	Homo sapiens	IC50	nM	360.0
	19485793	CHEMBL4481511	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	Clc1cc2cc(c1)-c1cnn3ccc(nc13)NCCOCCO2		CHEMBL4531690	=	IC50	nM	0.011	CHEMBL5014	Homo sapiens	IC50	nM	0.011
Not Determined	19485794	CHEMBL4481511	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499		IC50			CHEMBL5014	Homo sapiens	IC50		
Not Determined	19485795	CHEMBL4481511	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	Cc1[nH]nc(Nc2ncnc3cc(OCCO)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4535001		IC50			CHEMBL5014	Homo sapiens	IC50		
	19485796	CHEMBL4481511	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	IC50	nM	2.0	CHEMBL5014	Homo sapiens	IC50	uM	0.002
Not Active	19485797	CHEMBL4481512	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells upto 10 uM after 2 hrs by NanoBRET target engagement assay	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865		Activity			CHEMBL5014	Homo sapiens	Activity		
Not Active	19485798	CHEMBL4481512	Displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells upto 10 uM after 2 hrs by NanoBRET target engagement assay	B	COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL4462395		Activity			CHEMBL5014	Homo sapiens	Activity		
	19485821	CHEMBL4481524	Binding affinity to biotinylated human RIPK2 (1 to 310 residues) expressed in Escherichia coli at 1 uM incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	>	Activity	%	50.0	CHEMBL5014	Homo sapiens	Activity	%	50.0
	19485825	CHEMBL4481528	Ratio of IC50 for displacement of fluorescent tracer from N-terminus of human RIPK2 expressed in HEK293T cells after 2 hrs by NanoBRET target engagement assay to Kd for binding affinity to biotinylated human GAK (13 to 338 residues) expressed in Escherichia coli incubated for 1.5 hrs by fluorescent tracer dependent TR-FRET based competitive ligand binding displacement assay	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Ratio		3.0	CHEMBL5014	Homo sapiens	Ratio		3.0
	20598222	CHEMBL4602946	Inhibition of human RIPK2	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	<	IC50	nM	1000.0	CHEMBL5014	Homo sapiens	IC50	uM	1.0
	20598223	CHEMBL4602946	Inhibition of human RIPK2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	IC50	nM	1000.0	CHEMBL5014	Homo sapiens	IC50	uM	1.0
	20606248	CHEMBL4604987	Inhibition of RIPK2 (unknown origin) at 2 uM caliper microfluidic kinase assay relative to control	B	CCN1CCN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)CC1		CHEMBL4636064	=	Inhibition	%	90.0	CHEMBL5014	Homo sapiens	INH	%	90.0
	22392152	CHEMBL4667247	Inhibition of tracer 178 binding to recombinant human His-tagged RIPK2 (1 to 299 residues) expressed in insect expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-1.0	CHEMBL5014	Homo sapiens	INH	%	-1.0
	22393865	CHEMBL4667717	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc(Nc2ccnc3ccc(Br)cc23)cc(OC)c1OC		CHEMBL4443342	=	Kd	nM	110.0	CHEMBL5014	Homo sapiens	Kd	nM	110.0
	22393866	CHEMBL4667717	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC		CHEMBL311959	=	Kd	nM	190.0	CHEMBL5014	Homo sapiens	Kd	nM	190.0
	22393867	CHEMBL4667717	Binding affinity to wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cc(Nc2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC		CHEMBL535429	=	Kd	nM	890.0	CHEMBL5014	Homo sapiens	Kd	nM	890.0
	22419230	CHEMBL4672975	Inhibition of RIPK2 (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CC1NCCC=C1c1cc2c(Nc3ccc4scnc4c3)ccnc2s1		CHEMBL4797604	<=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	22419231	CHEMBL4672975	Inhibition of RIPK2 (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C1=C(c2cc3c(Nc4ccc5scnc5c4)ccnc3s2)C2(CCOC2)NC1		CHEMBL4758780	<=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	22419232	CHEMBL4672975	Inhibition of RIPK2 (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C1=C(c2cc3c(Nc4ccc5scnc5c4)ccnc3s2)C2(CCOCC2)NC1		CHEMBL4795029	<=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	22419233	CHEMBL4672975	Inhibition of RIPK2 (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CC1NCCC1c1cc2c(Nc3cc4ncsc4cc3F)ccnc2s1		CHEMBL4792570	<=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	22419234	CHEMBL4672975	Inhibition of RIPK2 (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	C1=C(c2cc3c(Nc4ccc5scnc5c4)ccnc3s2)CCNCC1		CHEMBL4758737	<=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	22419235	CHEMBL4672975	Inhibition of RIPK2 (unknown origin) incubated for 1 hr by Lanthascreen TR-FRET assay	B	CC1C(c2cc3c(Nc4ccc5scnc5c4)c(F)cnc3s2)CCCN1C		CHEMBL4763647	<=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	IC50	nM	10.0
	22423277	CHEMBL4674214	Inhibition of human RIPK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	68.05	CHEMBL5014	Homo sapiens	Activity	%	68.05
	22423278	CHEMBL4674214	Inhibition of human RIPK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	20.45	CHEMBL5014	Homo sapiens	Activity	%	20.45
	22804205	CHEMBL4712067	Inhibition of RIPK2 (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	COc1ccc(-n2cc(-c3ccc4nonc4c3)c3cc(-c4ccc(C(=O)O)cc4)cnc32)cc1		CHEMBL4747136	=	Inhibition	%	-3.0	CHEMBL5014	Homo sapiens	INH	%	-3.0
	22804206	CHEMBL4712067	Inhibition of RIPK2 (unknown origin) at 100 uM pre-incubated for 20 mins followed by 33P-gamma-ATP addition and measured after 120 mins by filter-binding method relative to control	B	O=C(O)c1ccc(-c2cnc3[nH]cc(-c4ccc5nonc5c4)c3c2)cc1		CHEMBL4752578	=	Inhibition	%	60.0	CHEMBL5014	Homo sapiens	INH	%	60.0
	22818129	CHEMBL4715352	Inhibition of recombinant human N-terminal His6-tagged RIPK2 (1 to 299 residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using MBP as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL5014	Homo sapiens	INH	%	50.0
	22843584	CHEMBL4720570	Inhibition of human RIPK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	395.0	CHEMBL5014	Homo sapiens	IC50	10^-7M	3.95
	22843928	CHEMBL4720914	Inhibition of human RIPK2 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	64.3	CHEMBL5014	Homo sapiens	Activity	%	64.3
	22844851	CHEMBL4721526	Inhibition of wild-type human partial length RIPK2 (M1 to K310 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	91.73	CHEMBL5014	Homo sapiens	Activity	%	91.73
	22845455	CHEMBL4721736	Binding affinity to Nluc-tagged RIPK2 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	0.91	CHEMBL5014	Homo sapiens	deltaTm	degrees C	0.91
	22886533	CHEMBL4728257	Binding affinity to RIPK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	4.0	CHEMBL5014	Homo sapiens	deltaTm	degrees C	4.0
	22949402	CHEMBL4765794	Inhibition of human RIPK2 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	108.0	CHEMBL5014	Homo sapiens	Activity	%	108.0
	22949403	CHEMBL4765794	Inhibition of human RIPK2 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	94.0	CHEMBL5014	Homo sapiens	Activity	%	94.0
	22949404	CHEMBL4765794	Inhibition of human RIPK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	104.0	CHEMBL5014	Homo sapiens	Activity	%	104.0
	22949405	CHEMBL4765794	Inhibition of human RIPK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	96.0	CHEMBL5014	Homo sapiens	Activity	%	96.0
	22949406	CHEMBL4765794	Inhibition of human RIPK2 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	22949407	CHEMBL4765794	Inhibition of human RIPK2 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	102.0	CHEMBL5014	Homo sapiens	Activity	%	102.0
	22949408	CHEMBL4765795	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	22949409	CHEMBL4765795	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	89.0	CHEMBL5014	Homo sapiens	Activity	%	89.0
	22949410	CHEMBL4765795	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	95.0	CHEMBL5014	Homo sapiens	Activity	%	95.0
	22949411	CHEMBL4765795	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	48.0	CHEMBL5014	Homo sapiens	Activity	%	48.0
	22949412	CHEMBL4765795	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	97.0	CHEMBL5014	Homo sapiens	Activity	%	97.0
	22949413	CHEMBL4765795	Inhibition of human RIPK2 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	84.0	CHEMBL5014	Homo sapiens	Activity	%	84.0
	22952982	CHEMBL4766919	Inhibition of recombinant human RIPK2 (1 to 299 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 120 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	27.0	CHEMBL5014	Homo sapiens	Activity	%	27.0
	22972851	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(OC)c1OC		CHEMBL3341789	=	IC50	nM	100.0	CHEMBL5014	Homo sapiens	IC50	nM	100.0
	22972852	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(NS(C)(=O)=O)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4779127	=	IC50	nM	296.0	CHEMBL5014	Homo sapiens	IC50	nM	296.0
	22972853	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCS(=O)(=O)Nc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4776443	=	IC50	nM	127.0	CHEMBL5014	Homo sapiens	IC50	nM	127.0
	22972854	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4782562	=	IC50	nM	164.0	CHEMBL5014	Homo sapiens	IC50	nM	164.0
	22972855	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)c1		CHEMBL4792227	=	IC50	nM	76.0	CHEMBL5014	Homo sapiens	IC50	nM	76.0
	22972856	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(NS(C)(=O)=O)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4784430	=	IC50	nM	51.0	CHEMBL5014	Homo sapiens	IC50	nM	51.0
	22972857	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(OC)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4800115	=	IC50	nM	14.0	CHEMBL5014	Homo sapiens	IC50	nM	14.0
	22972858	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4781705	=	IC50	nM	13.0	CHEMBL5014	Homo sapiens	IC50	nM	13.0
	22972859	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(NS(=O)(=O)c2ccccc2)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4776631	=	IC50	nM	23.0	CHEMBL5014	Homo sapiens	IC50	nM	23.0
	22972860	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCOc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4795976	=	IC50	nM	21.0	CHEMBL5014	Homo sapiens	IC50	nM	21.0
	22972861	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CC(C)Oc1cc(NS(=O)(=O)C(C)C)cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)c1		CHEMBL4792496	=	IC50	nM	18.0	CHEMBL5014	Homo sapiens	IC50	nM	18.0
	22972862	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1OC		CHEMBL4786742	=	IC50	nM	32.0	CHEMBL5014	Homo sapiens	IC50	nM	32.0
	22972863	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1O		CHEMBL4786295	=	IC50	nM	54.0	CHEMBL5014	Homo sapiens	IC50	nM	54.0
	22972864	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1C		CHEMBL4800562	=	IC50	nM	102.0	CHEMBL5014	Homo sapiens	IC50	nM	102.0
	22972865	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1OC		CHEMBL4781373	=	IC50	nM	20.0	CHEMBL5014	Homo sapiens	IC50	nM	20.0
	22972866	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc2c1OCCO2		CHEMBL4789064	=	IC50	nM	520.0	CHEMBL5014	Homo sapiens	IC50	nM	520.0
	22972867	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(C)c1OC		CHEMBL4788375	=	IC50	nM	41.0	CHEMBL5014	Homo sapiens	IC50	nM	41.0
	22972868	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(F)c1OC		CHEMBL4789724	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	nM	16.0
	22972869	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(Cl)c1OC		CHEMBL4793153	=	IC50	nM	21.0	CHEMBL5014	Homo sapiens	IC50	nM	21.0
	22972870	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	COc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(F)c1OC		CHEMBL4781201	=	IC50	nM	39.0	CHEMBL5014	Homo sapiens	IC50	nM	39.0
	22972871	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)NCc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)ccc1OC		CHEMBL4783273	=	IC50	nM	99.0	CHEMBL5014	Homo sapiens	IC50	nM	99.0
	22972872	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)N1CCc2ccc(-c3cc(-c4ccc(N5CCNCC5)cc4)cnc3N)cc21		CHEMBL4792038	=	IC50	nM	185.0	CHEMBL5014	Homo sapiens	IC50	nM	185.0
	22972873	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)N1CCOc2ccc(-c3cc(-c4ccc(N5CCNCC5)cc4)cnc3N)cc21		CHEMBL4797951	=	IC50	nM	78.0	CHEMBL5014	Homo sapiens	IC50	nM	78.0
	22972874	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2)cc(F)c1OC		CHEMBL4782505	=	IC50	nM	27.0	CHEMBL5014	Homo sapiens	IC50	nM	27.0
	22972875	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc(F)c1OC		CHEMBL4798442	=	IC50	nM	1414.0	CHEMBL5014	Homo sapiens	IC50	nM	1414.0
	22972876	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3cccc(S(C)(=O)=O)c3)cnc2N)ccc1OC		CHEMBL4780183	=	IC50	nM	103.0	CHEMBL5014	Homo sapiens	IC50	nM	103.0
	22972877	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(S(C)(=O)=O)cc3)cnc2N)ccc1OC		CHEMBL4800323	=	IC50	nM	264.0	CHEMBL5014	Homo sapiens	IC50	nM	264.0
	22972878	CHEMBL4771083	Inhibition of recombinant human RIPK2 incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3cccc(N4CCNCC4)c3)cnc2N)cc(F)c1OC		CHEMBL4799077	=	IC50	nM	11.0	CHEMBL5014	Homo sapiens	IC50	nM	11.0
Not Active	22972938	CHEMBL4771096	Inhibition of recombinant human RIPK2 at 10 uM incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1ccc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2C)cc1OC		CHEMBL4786544		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	22972939	CHEMBL4771096	Inhibition of recombinant human RIPK2 at 10 uM incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccccc3S(C)(=O)=O)cnc2N)ccc1OC		CHEMBL4778280		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	22972940	CHEMBL4771096	Inhibition of recombinant human RIPK2 at 10 uM incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OCC)c1OC		CHEMBL4783654		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	22972941	CHEMBL4771096	Inhibition of recombinant human RIPK2 at 10 uM incubated for 2 hr by ADP-Glo assay	B	CCCS(=O)(=O)Nc1cc(-c2cc(-c3ccc(N4CCNCC4)cc3)cnc2N)cc(OC)c1C		CHEMBL4781290		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	23122793	CHEMBL4805144	Inhibition of human RIPK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	23123488	CHEMBL4805732	Inhibition of human RIPK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	94.0	CHEMBL5014	Homo sapiens	Activity	%	94.0
	23123943	CHEMBL4806187	Inhibition of DNA-tagged human RIPK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	23125066	CHEMBL4806749	Inhibition of human RIPK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5014	Homo sapiens	Activity	%	100.0
	23125067	CHEMBL4806749	Inhibition of human RIPK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	93.0	CHEMBL5014	Homo sapiens	Activity	%	93.0
	23128524	CHEMBL4807983	Inhibition of RIPK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL5014	Homo sapiens	Activity	%	25.0
	23128525	CHEMBL4807983	Inhibition of RIPK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL5014	Homo sapiens	Activity	%	25.0
	23128526	CHEMBL4807983	Inhibition of RIPK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL5014	Homo sapiens	Activity	%	25.0
	23128862	CHEMBL4808077	Inhibition of RIPK2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	63.0	CHEMBL5014	Homo sapiens	INH	%	63.0
	23128863	CHEMBL4808077	Inhibition of RIPK2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	65.0	CHEMBL5014	Homo sapiens	INH	%	65.0
	23128864	CHEMBL4808077	Inhibition of RIPK2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(NC)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4855979	=	Inhibition	%	40.0	CHEMBL5014	Homo sapiens	INH	%	40.0
	23128865	CHEMBL4808077	Inhibition of RIPK2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	51.0	CHEMBL5014	Homo sapiens	INH	%	51.0
	23177353	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	IC50	nM	13.0	CHEMBL5014	Homo sapiens	IC50	uM	0.013000000000000001
	23177354	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(Cl)cc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL4849134	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	uM	0.016
	23177355	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL4853179	=	IC50	nM	17.0	CHEMBL5014	Homo sapiens	IC50	uM	0.017
	23177356	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(Cl)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4852860	=	IC50	nM	13.0	CHEMBL5014	Homo sapiens	IC50	uM	0.013000000000000001
	23177357	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(C(C)(C)C)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4854929	=	IC50	nM	105.0	CHEMBL5014	Homo sapiens	IC50	uM	0.105
	23177358	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(O)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4870434	=	IC50	nM	25.0	CHEMBL5014	Homo sapiens	IC50	uM	0.025
	23177359	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(OC)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4852513	=	IC50	nM	21.0	CHEMBL5014	Homo sapiens	IC50	uM	0.021
	23177360	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4)c(=O)n(C)c3n2)cc1		CHEMBL136244	=	IC50	nM	10.5	CHEMBL5014	Homo sapiens	IC50	uM	0.0105
	23177361	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4)c(=O)n(CC)c3n2)cc1		CHEMBL136106	=	IC50	nM	30000.0	CHEMBL5014	Homo sapiens	IC50	uM	30.0
	23177362	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4)c(=O)n(CCO)c3n2)cc1		CHEMBL4871544	=	IC50	nM	30000.0	CHEMBL5014	Homo sapiens	IC50	uM	30.0
	23177363	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(CCOC)c3n2)cc1		CHEMBL4859716	=	IC50	nM	128.0	CHEMBL5014	Homo sapiens	IC50	uM	0.128
	23177364	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4ccccc4)c3n2)cc1		CHEMBL4858463	=	IC50	nM	21.0	CHEMBL5014	Homo sapiens	IC50	uM	0.021
	23177365	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(CC(C)C)c3n2)cc1		CHEMBL4847211	=	IC50	nM	5.0	CHEMBL5014	Homo sapiens	IC50	uM	0.005
	23177366	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4cccc(S(C)(=O)=O)c4)c3n2)cc1		CHEMBL4864576	=	IC50	nM	25.0	CHEMBL5014	Homo sapiens	IC50	uM	0.025
	23177367	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(Cc4ccc(S(C)(=O)=O)cc4)c3n2)cc1		CHEMBL4874031	=	IC50	nM	21.0	CHEMBL5014	Homo sapiens	IC50	uM	0.021
	23177368	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(S(C)(=O)=O)cc3)nc21		CHEMBL4868894	=	IC50	nM	14.0	CHEMBL5014	Homo sapiens	IC50	uM	0.013999999999999999
	23177369	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4864600	=	IC50	nM	6.0	CHEMBL5014	Homo sapiens	IC50	uM	0.006
	23177370	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2ccc(Cl)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4864714	=	IC50	nM	14.6	CHEMBL5014	Homo sapiens	IC50	uM	0.0146
	23177371	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	CC(C)Cn1c(=O)c(-c2ccc(Cl)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4856366	=	IC50	nM	64.7	CHEMBL5014	Homo sapiens	IC50	uM	0.0647
	23177372	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4861488	=	IC50	nM	8.0	CHEMBL5014	Homo sapiens	IC50	uM	0.008
	23177373	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2ccc(Cl)cc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4859351	=	IC50	nM	27.0	CHEMBL5014	Homo sapiens	IC50	uM	0.027000000000000003
	23177374	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2cccc(Cl)c2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4847571	=	IC50	nM	34.0	CHEMBL5014	Homo sapiens	IC50	uM	0.034
	23177375	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2ccc(F)cc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4867716	=	IC50	nM	17.0	CHEMBL5014	Homo sapiens	IC50	uM	0.017
	23177376	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2cc(Cl)ccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4853711	=	IC50	nM	22.0	CHEMBL5014	Homo sapiens	IC50	uM	0.022000000000000002
	23177377	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cc1ccc(-c2cc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc3n(C)c2=O)c(Cl)c1		CHEMBL4875011	=	IC50	nM	15.0	CHEMBL5014	Homo sapiens	IC50	uM	0.015
	23177378	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	Cn1c(=O)c(-c2ccc(O)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4867467	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	uM	0.016
	23177379	CHEMBL4815729	Inhibition of recombinant RIPK2 (unknown origin) using RS repeat peptide as substrate preincubated for 5 mins followed by substrate and ATP addition and further incubated for 2 hrs by ADP-Glo reagent based assay	B	COc1ccc(-c2cc3cnc(Nc4cccc(S(C)(=O)=O)c4)nc3n(C)c2=O)cc1		CHEMBL4861447	=	IC50	nM	11.0	CHEMBL5014	Homo sapiens	IC50	uM	0.011000000000000001
Active	23177403	CHEMBL4815731	Inhibition of RIPK2 in NOD2 positive human U2OS cells assessed as reduction in L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL4853179		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Active	23177404	CHEMBL4815731	Inhibition of RIPK2 in NOD2 positive human U2OS cells assessed as reduction in L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(Cl)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4852860		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Active	23177405	CHEMBL4815731	Inhibition of RIPK2 in NOD2 positive human U2OS cells assessed as reduction in L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	Cn1c(=O)c(-c2ccc(Cl)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4864714		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Active	23177406	CHEMBL4815731	Inhibition of RIPK2 in NOD2 positive human U2OS cells assessed as reduction in L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4861488		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	23177407	CHEMBL4815732	Inhibition of RIPK2 T95W mutant in NOD2 positive human U2OS cells assessed as inhibition of L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL4853179		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	23177408	CHEMBL4815732	Inhibition of RIPK2 T95W mutant in NOD2 positive human U2OS cells assessed as inhibition of L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4ccc(Cl)cc4)c(=O)n(C)c3n2)cc1		CHEMBL4852860		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	23177409	CHEMBL4815732	Inhibition of RIPK2 T95W mutant in NOD2 positive human U2OS cells assessed as inhibition of L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	Cn1c(=O)c(-c2ccc(Cl)cc2)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4864714		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Not Active	23177410	CHEMBL4815732	Inhibition of RIPK2 T95W mutant in NOD2 positive human U2OS cells assessed as inhibition of L18-MDP stimulated CXCL8 expression measured by flow cytometry method	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4861488		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	23177420	CHEMBL4815742	Inhibition of RIPK2 in human U-937 cells	B	Cn1c(=O)c(-c2ccccc2Cl)cc2cnc(Nc3cccc(S(C)(=O)=O)c3)nc21		CHEMBL4861488	>	IC50	nM	4000.0	CHEMBL5014	Homo sapiens	IC50	uM	4.0
Active	23183236	CHEMBL4817055	Inhibition of RIPK2 (unknown origin) at 10 uM	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
Active	23183237	CHEMBL4817055	Inhibition of RIPK2 (unknown origin) at 10 uM	B	CC(C)S(=O)(=O)c1ccc2nccc(Nc3ccc4scnc4c3)c2c1		CHEMBL4779280		Inhibition	%		CHEMBL5014	Homo sapiens	INH		
	23240290	CHEMBL4829092	Inhibition of RIP2 (unknown origin) by fluorescence polarization based binding assay	B	COCCNC(=O)c1cc(CNc2ccc(Cl)c(O)c2)cc(-c2ccc3c(Cl)ccnc3c2)c1		CHEMBL4869360	>	IC50	nM	50000.0	CHEMBL5014	Homo sapiens	IC50	uM	50.0
	23240297	CHEMBL4829096	Relative binding affinity to RIP2 (unknown origin) by affinity selection mass spectrometry analysis	B	NC(=O)c1cc(C=O)cc(-c2ccc3c(Nc4ccc5scnc5c4)ccnc3c2)c1		CHEMBL4862116	=	RBA	%	70.0	CHEMBL5014	Homo sapiens	RBA	%	70.0
	23240298	CHEMBL4829096	Relative binding affinity to RIP2 (unknown origin) by affinity selection mass spectrometry analysis	B	NC(=O)c1cc(CNc2ccc3scnc3c2)cc(-c2ccc3c(Nc4ccc5scnc5c4)ccnc3c2)c1		CHEMBL4868971	=	RBA	%	58.0	CHEMBL5014	Homo sapiens	RBA	%	58.0
	23240299	CHEMBL4829096	Relative binding affinity to RIP2 (unknown origin) by affinity selection mass spectrometry analysis	B	COCCn1c(-c2cnc(-c3ccc(Cl)cc3)[nH]2)nc2cc(C(=O)NCCO)ccc21		CHEMBL4872947	=	RBA	%	30.0	CHEMBL5014	Homo sapiens	RBA	%	30.0
	23240300	CHEMBL4829097	Inhibition of RIP2 (unknown origin)	B	Oc1cc(Nc2ccnc3cc(-c4ccccc4)ccc23)ccc1Cl		CHEMBL4873767	=	IC50	nM	6.0	CHEMBL5014	Homo sapiens	IC50	nM	6.0
	23240301	CHEMBL4829097	Inhibition of RIP2 (unknown origin)	B	c1ccc(-c2ccc3c(Nc4ccc5scnc5c4)ccnc3c2)cc1		CHEMBL4876135	=	IC50	nM	16.0	CHEMBL5014	Homo sapiens	IC50	nM	16.0
	23240302	CHEMBL4829098	Inhibition of RIP2 (unknown origin) by biochemical assay	B	COCCNC(=O)c1cc(CNc2ccc(Cl)c(O)c2)cc(-c2ccc3c(Nc4ccc(Cl)c(O)c4)ccnc3c2)c1		CHEMBL4869572	=	IC50	nM	6.0	CHEMBL5014	Homo sapiens	IC50	nM	6.0
	23260485	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(OCCOCCOCCOCCOc3cc4nccc(Nc5ccc6scnc6c5)c4cc3S(=O)(=O)C(C)(C)C)ccc2C[C@@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C		CHEMBL4863839	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	pIC50		8.0
	23260486	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CC[C@@H](NC(=O)[C@@H]1C[C@H](NC(=O)COCCOCCOCCOCCOc2cc3nccc(Nc4ccc5scnc5c4)c3cc2S(=O)(=O)C(C)(C)C)CN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C(C)(C)C)c1ccccc1		CHEMBL4856422	=	IC50	nM	1.995	CHEMBL5014	Homo sapiens	pIC50		8.7
	23260487	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)COCCOCCOCCOCCOc2cc3nccc(Nc4ccc5scnc5c4)c3cc2S(=O)(=O)C(C)(C)C)CC1		CHEMBL4872212	=	IC50	nM	5.012	CHEMBL5014	Homo sapiens	pIC50		8.3
	23260488	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1Cc2cc(OCCOCCOCCOCCOc3cc4ncnc(Nc5n[nH]c(C)c5C)c4cc3S(=O)(=O)C(C)(C)C)ccc2C[C@@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C		CHEMBL4852345	=	IC50	nM	398.11	CHEMBL5014	Homo sapiens	pIC50		6.4
	23260489	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)COCCOCCOCCOCCOc2cc3ncnc(Nc4n[nH]c(C)c4C)c3cc2S(=O)(=O)C(C)(C)C)CC1		CHEMBL4872484	=	IC50	nM	158.49	CHEMBL5014	Homo sapiens	pIC50		6.8
	23260490	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCC(COc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4860212	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	pIC50		8.0
	23260491	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCC(CCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4851924	=	IC50	nM	39.81	CHEMBL5014	Homo sapiens	pIC50		7.4
	23260492	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCC(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4864095	=	IC50	nM	31.62	CHEMBL5014	Homo sapiens	pIC50		7.5
	23260493	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCN(CCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4878694	=	IC50	nM	251.19	CHEMBL5014	Homo sapiens	pIC50		6.6
	23260494	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4864469	=	IC50	nM	7.943	CHEMBL5014	Homo sapiens	pIC50		8.1
	23260495	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2ccc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cc2)CC1		CHEMBL4857717	=	IC50	nM	31.62	CHEMBL5014	Homo sapiens	pIC50		7.5
	23260496	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2ccc(N3CCN(CCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4851311	=	IC50	nM	125.89	CHEMBL5014	Homo sapiens	pIC50		6.9
	23260497	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2ccc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)nc2)CC1		CHEMBL4866917	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	pIC50		8.0
	23260498	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCN(CCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)CC1		CHEMBL4861005	=	IC50	nM	158.49	CHEMBL5014	Homo sapiens	pIC50		6.8
	23260499	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCN(C(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)CC1		CHEMBL4876228	=	IC50	nM	12.59	CHEMBL5014	Homo sapiens	pIC50		7.9
	23260500	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@H](C)C(=O)N[C@@H](C(=O)N1C[C@@H](NC(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)C[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C(C)(C)C		CHEMBL4866182	=	IC50	nM	0.1585	CHEMBL5014	Homo sapiens	pIC50		9.8
	23260501	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)CC[C@H]2CC[C@@H](C(=O)N[C@@H]3CCCc4ccccc43)N2C1=O		CHEMBL4857880	=	IC50	nM	0.1	CHEMBL5014	Homo sapiens	pIC50		10.0
	23260502	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)C[C@H]1C(=O)Nc1c(F)cccc1F)C(C)(C)C		CHEMBL4863259	=	IC50	nM	10.0	CHEMBL5014	Homo sapiens	pIC50		8.0
	23260503	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	Cc1[nH]nc(Nc2ncnc3cc(OCCCN4CCN(C(=O)c5cnc(N6CCN(C[C@H]7CN[C@H](C)CN7CC(=O)N7CC(C)(C)c8ncc(Cc9ccc(F)cc9)cc87)[C@H](C)C6)nc5)CC4)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4860242	=	IC50	nM	25.12	CHEMBL5014	Homo sapiens	pIC50		7.6
	23260504	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	Cc1[nH]nc(Nc2ncnc3cc(OCCCN4CCN(C(=O)c5cnc(N6CCN(C[C@H]7CN[C@H](C)CN7CC(=O)N7CC(C)(C)c8c7cc(Cc7ccc(F)cc7)c(=O)n8C)[C@H](C)C6)nc5)CC4)c(S(=O)(=O)C(C)(C)C)cc23)c1C		CHEMBL4870089	=	IC50	nM	7.943	CHEMBL5014	Homo sapiens	pIC50		8.1
	23260505	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](NC(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)CC1C(=O)NC1CCCc2ccccc21)C(C)(C)C		CHEMBL4845683	=	IC50	nM	12.59	CHEMBL5014	Homo sapiens	pIC50		7.9
	23260506	CHEMBL4832944	Inhibition of full length His-tagged RIPK2 (unknown origin) expressed in baculovirus expression system using fluorescent labelled ATP competitive ligand by fluorescent polarization based binding assay	B	CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2cnc(N3CCN(CCCOc4cc5ncnc(Nc6n[nH]c(C)c6C)c5cc4S(=O)(=O)C(C)(C)C)CC3)cn2)CC[C@H]2CC[C@@H](C(=O)NC3CCCc4ccccc43)N2C1=O		CHEMBL4848861	=	IC50	nM	6.31	CHEMBL5014	Homo sapiens	pIC50		8.2
Not Active	23317629	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	91.0	CHEMBL5014	Homo sapiens	% Control	%	91.0
Not Active	23318097	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	65.0	CHEMBL5014	Homo sapiens	% Control	%	65.0
Not Active	23318763	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23319247	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23319884	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23320359	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23321037	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23321505	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23322135	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23322603	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	84.0	CHEMBL5014	Homo sapiens	% Control	%	84.0
Not Active	23323292	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	94.0	CHEMBL5014	Homo sapiens	% Control	%	94.0
Not Active	23323760	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23324119	CHEMBL4880738	RIPK2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	5.0	CHEMBL5014	Homo sapiens	% inhibition	%	5.0
Not Active	23324614	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	92.0	CHEMBL5014	Homo sapiens	% Control	%	92.0
Not Active	23325249	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23325717	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	97.0	CHEMBL5014	Homo sapiens	% Control	%	97.0
Not Active	23326364	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	94.0	CHEMBL5014	Homo sapiens	% Control	%	94.0
Not Active	23326832	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	93.0	CHEMBL5014	Homo sapiens	% Control	%	93.0
Not Active	23327532	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23328000	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23328587	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23329055	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	93.0	CHEMBL5014	Homo sapiens	% Control	%	93.0
Not Active	23329509	CHEMBL4881216	RIPK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	101.0	CHEMBL5014	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23330001	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23330469	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	94.0	CHEMBL5014	Homo sapiens	% Control	%	94.0
Not Active	23331225	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	90.0	CHEMBL5014	Homo sapiens	% Control	%	90.0
Not Active	23331693	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23332280	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	84.5	CHEMBL5014	Homo sapiens	% Control	%	84.5
Not Active	23332746	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	88.6	CHEMBL5014	Homo sapiens	% Control	%	88.6
Not Active	23333464	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	98.7	CHEMBL5014	Homo sapiens	% Control	%	98.7
Not Active	23334103	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23334571	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23335550	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	92.0	CHEMBL5014	Homo sapiens	% Control	%	92.0
Not Active	23336018	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	83.0	CHEMBL5014	Homo sapiens	% Control	%	83.0
Not Active	23336645	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	64.0	CHEMBL5014	Homo sapiens	% Control	%	64.0
Not Active	23337113	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23337758	CHEMBL4882129	RIPK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	91.0	CHEMBL5014	Homo sapiens	% Ctrl	%	91.0
Not Active	23338194	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	87.0	CHEMBL5014	Homo sapiens	% Control	%	87.0
Not Active	23338662	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23339274	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	67.0	CHEMBL5014	Homo sapiens	% Control	%	67.0
Not Active	23339742	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23340379	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	53.0	CHEMBL5014	Homo sapiens	% Control	%	53.0
Not Active	23340847	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23341504	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23341972	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23342588	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23343056	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	85.0	CHEMBL5014	Homo sapiens	% Control	%	85.0
Not Active	23343686	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23344154	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23344792	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	71.0	CHEMBL5014	Homo sapiens	% Control	%	71.0
Not Active	23345365	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23345833	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23346410	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	83.8	CHEMBL5014	Homo sapiens	% Control	%	83.8
Not Active	23346878	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	96.8	CHEMBL5014	Homo sapiens	% Control	%	96.8
Not Active	23347480	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	90.3	CHEMBL5014	Homo sapiens	% Control	%	90.3
Not Active	23347970	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	77.0	CHEMBL5014	Homo sapiens	% Control	%	77.0
Not Active	23348549	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23349017	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	96.0	CHEMBL5014	Homo sapiens	% Control	%	96.0
Not Active	23349604	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	84.0	CHEMBL5014	Homo sapiens	% Control	%	84.0
Not Active	23350222	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23350690	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	93.0	CHEMBL5014	Homo sapiens	% Control	%	93.0
Not Active	23351295	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	92.0	CHEMBL5014	Homo sapiens	% Control	%	92.0
Not Active	23351763	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23352210	CHEMBL4882899	RIPK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.0326	CHEMBL5014	Homo sapiens	% Inhibition	%	-0.0326
Not Active	23352787	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23353255	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23354137	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23354605	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23355337	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23355805	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23356441	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23356909	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23357518	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	82.0	CHEMBL5014	Homo sapiens	% Control	%	82.0
Not Active	23358165	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	94.0	CHEMBL5014	Homo sapiens	% Control	%	94.0
Not Active	23358633	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	93.0	CHEMBL5014	Homo sapiens	% Control	%	93.0
Not Active	23359219	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23359817	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	66.0	CHEMBL5014	Homo sapiens	% Control	%	66.0
Not Active	23360285	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL5014	Homo sapiens	% Control	%	88.0
Not Active	23360870	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	82.0	CHEMBL5014	Homo sapiens	% Control	%	82.0
Not Active	23361338	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	53.0	CHEMBL5014	Homo sapiens	% Control	%	53.0
Not Active	23361911	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	95.0	CHEMBL5014	Homo sapiens	% Control	%	95.0
Not Active	23362447	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23362915	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23364557	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	85.0	CHEMBL5014	Homo sapiens	% Control	%	85.0
Not Active	23365025	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23365764	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23366307	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	90.0	CHEMBL5014	Homo sapiens	% Control	%	90.0
Not Active	23366897	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	96.0	CHEMBL5014	Homo sapiens	% Control	%	96.0
Not Active	23367365	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	97.0	CHEMBL5014	Homo sapiens	% Control	%	97.0
Not Active	23367727	CHEMBL4884080	RIPK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	77.0	CHEMBL5014	Homo sapiens	% Residual activity with Skepinone-L	%	77.0
Not Active	23368243	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL5014	Homo sapiens	% Control	%	93.0
Not Active	23368711	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	96.0	CHEMBL5014	Homo sapiens	% Control	%	96.0
Not Active	23369310	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	71.0	CHEMBL5014	Homo sapiens	% Control	%	71.0
Slightly Active	23369778	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	37.0	CHEMBL5014	Homo sapiens	% Control	%	37.0
Not Active	23370223	CHEMBL4884465	RIPK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	115.0	CHEMBL5014	Homo sapiens	% residual kinase activity	%	115.0
Not Active	23370746	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23371214	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Slightly Active	23371634	CHEMBL4884595	NanoBRET (SGC-Frankfurt) (RIPK2)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1	Non standard unit for type	CHEMBL4591082	>	IC50	M	25.0	CHEMBL5014	Homo sapiens	IC50	M	25.0
Slightly Active	23372023	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	30.0	CHEMBL5014	Homo sapiens	% Control	%	30.0
Not Active	23372491	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	59.0	CHEMBL5014	Homo sapiens	% Control	%	59.0
	23372877	CHEMBL4884842	RIPK2(RIP2LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5014	Homo sapiens	pIC50		6.0
	23373286	CHEMBL4885133	RIPK2(RIP2LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5014	Homo sapiens	pIC50		6.0
	23373642	CHEMBL4885419	RIPK2(RIP2LGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5014	Homo sapiens	pIC50		6.0
Not Active	23375088	CHEMBL4886076	RIPK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	22.5	CHEMBL5014	Homo sapiens	% Inhibition	%	22.5
Not Active	23375364	CHEMBL4886346	receptor-interacting serine-threonine kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-6.0	CHEMBL5014	Homo sapiens	% inhibition	%	-6.0
Not Active	23375918	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	53.0	CHEMBL5014	Homo sapiens	% Control	%	53.0
Not Active	23376386	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	70.0	CHEMBL5014	Homo sapiens	% Control	%	70.0
Not Active	23376963	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	82.0	CHEMBL5014	Homo sapiens	% Control	%	82.0
Not Active	23377431	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23378291	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23378759	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	83.0	CHEMBL5014	Homo sapiens	% Control	%	83.0
Not Active	23379926	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	92.0	CHEMBL5014	Homo sapiens	% Control	%	92.0
Not Active	23380394	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	83.0	CHEMBL5014	Homo sapiens	% Control	%	83.0
Not Active	23381088	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23381736	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	68.0	CHEMBL5014	Homo sapiens	% Control	%	68.0
Not Active	23382204	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	91.0	CHEMBL5014	Homo sapiens	% Control	%	91.0
Not Active	23382828	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5014	Homo sapiens	% Control	%	100.0
Not Active	23383296	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	82.0	CHEMBL5014	Homo sapiens	% Control	%	82.0
Not Active	23383970	CHEMBL4887575	RIPK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	94.0	CHEMBL5014	Homo sapiens	% Ctrl	%	94.0
Not Active	23384446	CHEMBL4888041	RIPK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-29.87	CHEMBL5014	Homo sapiens	% inhibition	%	-29.87
Not Active	23385211	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	74.0	CHEMBL5014	Homo sapiens	% Control	%	74.0
Not Active	23385678	CHEMBL4879935	KinomeScan assay: inhibition of RIPK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	83.0	CHEMBL5014	Homo sapiens	% Control	%	83.0
